needhamfunds needhamfunds home contact us about us mutual funds hedge funds private equity news needham mutual funds growth fund aggressive growth fund small cap growth fund invest now literature center contact us daily nav growth fund as of fundtickernav changedaily ytd institutional classneeixretail classneegx pdf aggressive growth fund as of fundtickernav changedaily ytd institutional classneaixretail classneagx pdf small cap growth fund as of fundtickernav changedaily ytd institutional classnesixretail classnesgx pdf news feed view more news distribution information the needham funds have made the following distributions for  needham growth fund neegx      per share long term capital gain needham aggressive growth fund neagx      per share long term capital gain needham small cap growth fund nesgx      per share long term capital gain      per share short term capital gain record date  ex dividend and pay date  reinvest date for shareholders that have chosen that option  sign up for email updates needham growth insights needham growth insights dividends  a consideration in small cap investing needham growth insights what to look for in small caps needham growth insights why small caps view more insights the growth factor growth factor  preview of the th annual needham growth conference growth factor  educational briefs chapter  beta growth factor  the role of founders family  longtenured management in compounders growth factor  precision castparts  berkshire hathaway growth factor  needham growth conference preview growth factor  putting active share to work view more growth factors manager commentary chuck jaffes moneylife market call with john barr   portfolio managers commentary  st quarter  portfolio managers commentary  th quarter  portfolio managers commentary  rd quarter  portfolio managers commentary  nd quarter  portfolio managers commentary  st quarter  portfolio managers commentary  th quarter  wally forbes interviews john barr and chris retzler view more commentaries     home about us invest now literature center news contact us the foregoing should not be deemed as an offer to buy an interest in any of the needham funds the funds shares are sold only through the currently effective prospectus complete information on the needham funds including a current prospectus is available for downloading and should be read prior to making any decision to invest click here to go to the download library investment in the funds involves investment risk including the possible loss of principal please read the prospectus and consider the investment objectives risks and charges and expenses of the funds carefully before you invest the prospectus and the summary prospectus contain this and other information about the funds the results contained on this site represent past performance of the funds past performance does not guarantee future results and current performance may be higher or lower than these results performance current to the most recent monthend may be obtained by calling  the funds’ use of short sales options and futures strategies and leverage may result in significant capital loss although the fund is classified as “diversified” under the investment company act of  as amended the “ act” the fund may invest its assets in a smaller number of issuers than other more diversified funds the fund’s net asset value “nav” may be more vulnerable to changes in the market value of a single issuer or group of issuers and may be relatively more susceptible to adverse effects from any single corporate industry economic market political or regulatory occurrence than if the fund’s investments consisted of securities issued by a larger number of issuers total return figures include reinvestment of all dividends and capital gains investment returns and principal value will fluctuate and when redeemed shares may be worth more or less than their original cost shares held  days or less are subject to a shortterm redemption fee of  needham  company llc member finrasipc is the distributor of the needham funds inc these securities have not been approved or disapproved by the securities and exchange commission or any state securities commission nor has the securities and exchange commission or any state securities commission passed upon the accuracy or adequacy of this document any representation to the contrary is a criminal offense for details regarding the needham funds please contact needham investment management llc at  · needham  company llc  · needham funds  · needham capital partners  the needham group inc needham  company llc is a member of finra  sipc all rights reserved terms of use  privacy policy  business continuity plan needhamfunds needhamfunds home contact us about us mutual funds hedge funds private equity news about us needham funds inc is affiliated with needham asset management llc which manages over  million in public and private equity investments with an emphasis on taxefficient capital appreciation and preservation needham asset management seeks aboveaverage growth at value prices in varying styles of market capitalization and rate of growth targets george a needham chairman of the board and chief executive officer the needham group inc george needham cofounded needham  company in  a leading investment banking firm specializing in emerging growth companies he was formerly a managing director of the first boston corporation where he established its business development and technology groups during his year career prior to this he was a portfolio manager in the investment advisory division at bankers trust company he was a first lieutenant in the united states army and served as company commander of the rd transportation company in heidelberg west germany he is a graduate of bucknell university and the stanford graduate school of business john barr portfoliio manager john barr is a comanager of the needham growth fund neegx he has been its comanager since january  he also manages the needham aggressive growth fund neagx he engages in a variety of portfolio managementrelated activities including stock selection research company visits and market analysis he rejoined needham  company in august  from oliver investment management llc a longshort hedge fund focused on small cap technology and exploration and mining stocks of which john was the founding and managing member from  to  he served as a portfolio manager and analyst at buckingham capital management for their diversified industry longshort domestic equity hedge fund he focused on telecom semiconductors and software he also has experience with financials energy exploration and production and mining stocks from  to  john was a managing director and senior analyst at robertson stephens following semiconductor technology companies from  to  he was a managing director and senior analyst at needham  company he also served as its director of research john was an institutional investor allstar and was ranked by reuters as leader of one of the top software teams he is a graduate of harvard business school and colgate university chris retzler portfolio manager chris retzler is a comanager of the needham growth fund neegx he has been the comanager since january  he also manages the needham small cap growth fund nesgx since january  he joined needham asset management in  coming from winterkorn where he spent the previous three years prior to winterkorn chris was part of merrill lynchs investment banking from  to  he graduated with a ba from bucknell university in  moving on to become a fulbright scholar in  he received his mba from columbia business school in  needham mutual funds growth fund aggressive growth fund small cap growth fund invest now literature center the growth factor manager commentary contact us home about us invest now literature center news contact us the foregoing should not be deemed as an offer to buy an interest in any of the needham funds the funds shares are sold only through the currently effective prospectus complete information on the needham funds including a current prospectus is available for downloading and should be read prior to making any decision to invest click here to go to the download library investment in the funds involves investment risk including the possible loss of principal please read the prospectus and consider the investment objectives risks and charges and expenses of the funds carefully before you invest the prospectus and the summary prospectus contain this and other information about the funds the results contained on this site represent past performance of the funds past performance does not guarantee future results and current performance may be higher or lower than these results performance current to the most recent monthend may be obtained by calling  the funds’ use of short sales options and futures strategies and leverage may result in significant capital loss although the fund is classified as “diversified” under the investment company act of  as amended the “ act” the fund may invest its assets in a smaller number of issuers than other more diversified funds the fund’s net asset value “nav” may be more vulnerable to changes in the market value of a single issuer or group of issuers and may be relatively more susceptible to adverse effects from any single corporate industry economic market political or regulatory occurrence than if the fund’s investments consisted of securities issued by a larger number of issuers total return figures include reinvestment of all dividends and capital gains investment returns and principal value will fluctuate and when redeemed shares may be worth more or less than their original cost shares held  days or less are subject to a shortterm redemption fee of  needham  company llc member finrasipc is the distributor of the needham funds inc these securities have not been approved or disapproved by the securities and exchange commission or any state securities commission nor has the securities and exchange commission or any state securities commission passed upon the accuracy or adequacy of this document any representation to the contrary is a criminal offense for details regarding the needham funds please contact needham investment management llc at  · needham  company llc  · needham funds  · needham capital partners  the needham group inc needham  company llc is a member of finra  sipc all rights reserved terms of use  privacy policy  business continuity plan needhamfunds needhamfunds home contact us about us mutual funds hedge funds private equity news needham aggressive growth fund retail share neagx  institutional share neaix assets  m  inception date  investment objective the needham aggressive growth fund seeks longterm taxefficient capital appreciation by primarily investing in the equity securities of public companies with aboveaverage prospective longterm growth rates more specifically the funds investment style is to move early into emerging areas of rapid growth to stay with the leaders in established growth markets and to exit or short areas andor companies that the fund believes can no longer sustain strong aboveaverage growth profitability strategy invest in companies with strong growth potential potential for higher operating margins longterm sustainable growth disruptive products or services invest in companies addressing unmet needs invest in strong incentivized management teams invest in companies that are underfollowed by wall street utilize shorting techniques to dampen volatility invests in venturebacked postipo opportunities portfolio manager john barr telephone   email jbarrneedhamcocom john barr is the fund manager of the needham aggressive growth fund neagx since january  he also comanages the needham growth fund neegx he engages in a variety of portfolio managementrelated activities including stock selection research company visits and market analysis he rejoined needham  company in august  from oliver investment management llc a longshort hedge fund focused on small cap technology and exploration and mining stocks of which john was the founding and managing member from  to  he served as a portfolio manager and analyst at buckingham capital management for their diversified industry longshort domestic equity hedge fund he focused on telecom semiconductors and software he also has experience with financials energy exploration and production and mining stocks from  to  john was a managing director and senior analyst at robertson stephens following semiconductor technology companies from  to  he was a managing director and senior analyst at needham  company he also served as its director of research john was an institutional investor allstar and was ranked by reuters as leader of one of the top software teams he is a graduate of harvard business school and colgate university email newsletter sign up top  holdings pdf solutions inc  entegris inc  akamai technologies inc  gse systems inc  apple inc  kvh industries inc  super micro computer inc  formfactor inc  wageworks inc  reis inc  total  capitalization exposure   billion   –  billion   million –  billion    million  as of  manager qa manager qa content would go here manager commentary    q conference call audio    q conference call transcript    q pm commentary download    q pm commentary download    q pm commentary download    q pm commentary download fund statistics minimum initial investment  reatil share class neagx  for ira  institutional share class neaix  minimum subsequent investment no min for ira redemption fee  within  days proxy voting record needham mutual funds growth fund aggressive growth fund fact sheet performance holdings fund news prospectus small cap growth fund invest now literature center the growth factor manager commentary contact us       home about us invest now literature center news contact us the foregoing should not be deemed as an offer to buy an interest in any of the needham funds the funds shares are sold only through the currently effective prospectus complete information on the needham funds including a current prospectus is available for downloading and should be read prior to making any decision to invest click here to go to the download library investment in the funds involves investment risk including the possible loss of principal please read the prospectus and consider the investment objectives risks and charges and expenses of the funds carefully before you invest the prospectus and the summary prospectus contain this and other information about the funds the results contained on this site represent past performance of the funds past performance does not guarantee future results and current performance may be higher or lower than these results performance current to the most recent monthend may be obtained by calling  the funds’ use of short sales options and futures strategies and leverage may result in significant capital loss although the fund is classified as “diversified” under the investment company act of  as amended the “ act” the fund may invest its assets in a smaller number of issuers than other more diversified funds the fund’s net asset value “nav” may be more vulnerable to changes in the market value of a single issuer or group of issuers and may be relatively more susceptible to adverse effects from any single corporate industry economic market political or regulatory occurrence than if the fund’s investments consisted of securities issued by a larger number of issuers total return figures include reinvestment of all dividends and capital gains investment returns and principal value will fluctuate and when redeemed shares may be worth more or less than their original cost shares held  days or less are subject to a shortterm redemption fee of  needham  company llc member finrasipc is the distributor of the needham funds inc these securities have not been approved or disapproved by the securities and exchange commission or any state securities commission nor has the securities and exchange commission or any state securities commission passed upon the accuracy or adequacy of this document any representation to the contrary is a criminal offense for details regarding the needham funds please contact needham investment management llc at  · needham  company llc  · needham funds  · needham capital partners  the needham group inc needham  company llc is a member of finra  sipc all rights reserved terms of use  privacy policy  business continuity plan needhamfunds needhamfunds home contact us about us mutual funds hedge funds private equity news the growth factor  manager commentary click on the links below to view issues of our portfolio managers regular commentary the growth factor the growth factor is a series of regular commentary published by needham funds portfolio managers john barr and chris retzler and chief financial officer jim giangrasso in their monthly missives john chris and jim lend their viewpoint on thematic investing in growth stocks and discuss market and macroeconomic trends the growth factor vol   preview of the th annual needham growth conference the growth factor vol   educational briefs chapter  beta the growth factor vol   the role of founders family  longtenured management in compounders needham growth insights what to look for in small caps needham growth insights why small caps the growth factor vol   precision castparts  berkshire hathaway the growth factor vol   preview of the th annual needham growth conference the growth factor vol   putting active share to work the growth factor vol   active share  low turnover the growth factor vol   preview of the th annual needham growth conference the growth factor vol   nd act investing the growth factor vol   the wow factor the growth factor vol   the th americas cup  lessons in management the growth factor vol   preview of grants spring  conference  th annual needham  company llc healthcare conference the growth factor vol   profile of makism d mddd  a penny stock the growth factor vol   preview of needham growth conference the growth factor vol   in pursuit of tenbaggers the growth factor vol   are we in a bubble we say no but be careful out there the growth factor vol   preview of grants investment conference the growth factor vol   investment criteria and a few of our new stocks the growth factor vol   the wow factor the growth factor vol   why dividends matter the growth factor vol   preview of needham growth conference the growth factor vol   one up on wall street the growth factor vol   iphone  apples implications across our portfolios the growth factor vol   is the market rigged against the retail investor the growth factor vol   on the road with chris  john q conference call audio q conference call transcript chuck jaffes moneylife market call with john barr   john barr discusses investment methodology and his recent commentary the growth factor vol  on compounders with moneylife host chuck jaffe  john and chuck also talk about portfolio holdings vrx ipgp and odc  john gives a hold it or fold it answer on akam ads aapl gsvc and entg moneylife host chuck jaffe is senior columnist for marketwatch his three weekly columns are syndicated nationally and his your funds column is the most widely read feature on mutual fund investing in america in  chuck was named to mutualfundwires list of the  most influential people in fund distribution the only journalist ever to make the list forbes wally forbes interviews john barr   topic  stocks that have that wow factor – akam pdfs ipgp quarterly commentariesportfolio managers commentary  th quarter  portfolio managers commentary  rd quarter  portfolio managers commentary  nd quarter  portfolio managers commentary  st quarter  needham mutual funds growth fund aggressive growth fund small cap growth fund invest now literature center the growth factor manager commentary contact us home about us invest now literature center news contact us the foregoing should not be deemed as an offer to buy an interest in any of the needham funds the funds shares are sold only through the currently effective prospectus complete information on the needham funds including a current prospectus is available for downloading and should be read prior to making any decision to invest click here to go to the download library investment in the funds involves investment risk including the possible loss of principal please read the prospectus and consider the investment objectives risks and charges and expenses of the funds carefully before you invest the prospectus and the summary prospectus contain this and other information about the funds the results contained on this site represent past performance of the funds past performance does not guarantee future results and current performance may be higher or lower than these results performance current to the most recent monthend may be obtained by calling  the funds’ use of short sales options and futures strategies and leverage may result in significant capital loss although the fund is classified as “diversified” under the investment company act of  as amended the “ act” the fund may invest its assets in a smaller number of issuers than other more diversified funds the fund’s net asset value “nav” may be more vulnerable to changes in the market value of a single issuer or group of issuers and may be relatively more susceptible to adverse effects from any single corporate industry economic market political or regulatory occurrence than if the fund’s investments consisted of securities issued by a larger number of issuers total return figures include reinvestment of all dividends and capital gains investment returns and principal value will fluctuate and when redeemed shares may be worth more or less than their original cost shares held  days or less are subject to a shortterm redemption fee of  needham  company llc member finrasipc is the distributor of the needham funds inc these securities have not been approved or disapproved by the securities and exchange commission or any state securities commission nor has the securities and exchange commission or any state securities commission passed upon the accuracy or adequacy of this document any representation to the contrary is a criminal offense for details regarding the needham funds please contact needham investment management llc at  · needham  company llc  · needham funds  · needham capital partners  the needham group inc needham  company llc is a member of finra  sipc all rights reserved terms of use  privacy policy  business continuity plan needhamfunds needhamfunds home contact us about us mutual funds hedge funds private equity news contact us investor services    needham asset management llc jim giangrasso  park avenue new york ny  telephone   fax   email jgiangrassoneedhamcocom needham mutual funds growth fund aggressive growth fund small cap growth fund invest now literature center the growth factor manager commentary contact us home about us invest now literature center news contact us the foregoing should not be deemed as an offer to buy an interest in any of the needham funds the funds shares are sold only through the currently effective prospectus complete information on the needham funds including a current prospectus is available for downloading and should be read prior to making any decision to invest click here to go to the download library investment in the funds involves investment risk including the possible loss of principal please read the prospectus and consider the investment objectives risks and charges and expenses of the funds carefully before you invest the prospectus and the summary prospectus contain this and other information about the funds the results contained on this site represent past performance of the funds past performance does not guarantee future results and current performance may be higher or lower than these results performance current to the most recent monthend may be obtained by calling  the funds’ use of short sales options and futures strategies and leverage may result in significant capital loss although the fund is classified as “diversified” under the investment company act of  as amended the “ act” the fund may invest its assets in a smaller number of issuers than other more diversified funds the fund’s net asset value “nav” may be more vulnerable to changes in the market value of a single issuer or group of issuers and may be relatively more susceptible to adverse effects from any single corporate industry economic market political or regulatory occurrence than if the fund’s investments consisted of securities issued by a larger number of issuers total return figures include reinvestment of all dividends and capital gains investment returns and principal value will fluctuate and when redeemed shares may be worth more or less than their original cost shares held  days or less are subject to a shortterm redemption fee of  needham  company llc member finrasipc is the distributor of the needham funds inc these securities have not been approved or disapproved by the securities and exchange commission or any state securities commission nor has the securities and exchange commission or any state securities commission passed upon the accuracy or adequacy of this document any representation to the contrary is a criminal offense for details regarding the needham funds please contact needham investment management llc at  · needham  company llc  · needham funds  · needham capital partners  the needham group inc needham  company llc is a member of finra  sipc all rights reserved terms of use  privacy policy  business continuity plan needhamfunds needhamfunds home contact us about us mutual funds hedge funds private equity news hedge funds overview the needham hedge funds the funds offer the investment experience of needham asset management llc along with the extensive and focused equity investment analysis and expertise of needham  company llc the funds are traditional longshort style investment limited partnerships that invest primarily in the equities of public emerging growth companies the objective of the funds is to maximize longterm capital appreciation by investing in the equities of growth companies we focus on fundamental research and do not rely upon technical investing based upon computerbased stock selection technical analysis and charts including momentum investing our strategy focuses on investments in companies with aboveaverage longterm growth rates which we believe is a result of such companies being at the vortex of rapid and fundamental changes in the world economy driven by technological and demographic change the funds engage in short sales of stocks that we believe are overvalued and accumulate long positions in companies we believe are undervalued in addition the funds may invest in the equity and equityrelated securities of promising private companies most of our areas of investment as seen below focus on the benefits from the power of information technology areas of investment business services electronics technology healthcare  data management           semiconductorcapital equipment                  medical devices  telemarketing           telecommunicationnetworking           healthcare services  transaction processing                      data storage           biotechnology            software           pharmaceuticals industrial technology internet digital media  consumer  instumentation           branded products           oilfield services  exploration           specialty retailing           contract manufacturing           media           specialty materials           cable          how to invest needham emerging growth partners lp you must be an accredited investor within the meaning of regulation d under the securities act of  as amended needham contrarian fund lp you must be an accredited investor within the meaning of regulation d under the securities act of  as amended needham contrarian qp fund lp you must be an accredited investor within the meaning of regulation d under the securities act of  as amended you must also be a qualified purchaser within the meaning of section a of the investment company act of  as amended  act for inquiries regarding needham hedge funds please contact kathleen mumma needham asset management llc telephone   email kmummaneedhamcocom needham mutual funds growth fund aggressive growth fund small cap growth fund invest now literature center the growth factor manager commentary contact us home about us invest now literature center news contact us the foregoing should not be deemed as an offer to buy an interest in any of the needham funds the funds shares are sold only through the currently effective prospectus complete information on the needham funds including a current prospectus is available for downloading and should be read prior to making any decision to invest click here to go to the download library investment in the funds involves investment risk including the possible loss of principal please read the prospectus and consider the investment objectives risks and charges and expenses of the funds carefully before you invest the prospectus and the summary prospectus contain this and other information about the funds the results contained on this site represent past performance of the funds past performance does not guarantee future results and current performance may be higher or lower than these results performance current to the most recent monthend may be obtained by calling  the funds’ use of short sales options and futures strategies and leverage may result in significant capital loss although the fund is classified as “diversified” under the investment company act of  as amended the “ act” the fund may invest its assets in a smaller number of issuers than other more diversified funds the fund’s net asset value “nav” may be more vulnerable to changes in the market value of a single issuer or group of issuers and may be relatively more susceptible to adverse effects from any single corporate industry economic market political or regulatory occurrence than if the fund’s investments consisted of securities issued by a larger number of issuers total return figures include reinvestment of all dividends and capital gains investment returns and principal value will fluctuate and when redeemed shares may be worth more or less than their original cost shares held  days or less are subject to a shortterm redemption fee of  needham  company llc member finrasipc is the distributor of the needham funds inc these securities have not been approved or disapproved by the securities and exchange commission or any state securities commission nor has the securities and exchange commission or any state securities commission passed upon the accuracy or adequacy of this document any representation to the contrary is a criminal offense for details regarding the needham funds please contact needham investment management llc at  · needham  company llc  · needham funds  · needham capital partners  the needham group inc needham  company llc is a member of finra  sipc all rights reserved terms of use  privacy policy  business continuity plan needham funds inc company profile  bloomberg feedback needham funds inc private company company profile sector financials industry asset management subindustry investment management the needham funds inc is a fund management firm the companys line of business includes issuing shares managing investment funds and mutual fund sales corporate information address  park avenue new york ny  united states phone  fax  web url wwwneedhamcocom from the web sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data needhamfunds needhamfunds home contact us about us mutual funds hedge funds private equity news needham aggressive growth fund retail share neagx  institutional share neaix assets  m  inception date  investment objective the needham aggressive growth fund seeks longterm taxefficient capital appreciation by primarily investing in the equity securities of public companies with aboveaverage prospective longterm growth rates more specifically the funds investment style is to move early into emerging areas of rapid growth to stay with the leaders in established growth markets and to exit or short areas andor companies that the fund believes can no longer sustain strong aboveaverage growth profitability strategy invest in companies with strong growth potential potential for higher operating margins longterm sustainable growth disruptive products or services invest in companies addressing unmet needs invest in strong incentivized management teams invest in companies that are underfollowed by wall street utilize shorting techniques to dampen volatility invests in venturebacked postipo opportunities portfolio manager john barr telephone   email jbarrneedhamcocom john barr is the fund manager of the needham aggressive growth fund neagx since january  he also comanages the needham growth fund neegx he engages in a variety of portfolio managementrelated activities including stock selection research company visits and market analysis he rejoined needham  company in august  from oliver investment management llc a longshort hedge fund focused on small cap technology and exploration and mining stocks of which john was the founding and managing member from  to  he served as a portfolio manager and analyst at buckingham capital management for their diversified industry longshort domestic equity hedge fund he focused on telecom semiconductors and software he also has experience with financials energy exploration and production and mining stocks from  to  john was a managing director and senior analyst at robertson stephens following semiconductor technology companies from  to  he was a managing director and senior analyst at needham  company he also served as its director of research john was an institutional investor allstar and was ranked by reuters as leader of one of the top software teams he is a graduate of harvard business school and colgate university email newsletter sign up top  holdings pdf solutions inc  entegris inc  akamai technologies inc  gse systems inc  apple inc  kvh industries inc  super micro computer inc  formfactor inc  wageworks inc  reis inc  total  capitalization exposure   billion   –  billion   million –  billion    million  as of  manager qa manager qa content would go here manager commentary    q conference call audio    q conference call transcript    q pm commentary download    q pm commentary download    q pm commentary download    q pm commentary download fund statistics minimum initial investment  reatil share class neagx  for ira  institutional share class neaix  minimum subsequent investment no min for ira redemption fee  within  days proxy voting record needham mutual funds growth fund aggressive growth fund fact sheet performance holdings fund news prospectus small cap growth fund invest now literature center the growth factor manager commentary contact us       home about us invest now literature center news contact us the foregoing should not be deemed as an offer to buy an interest in any of the needham funds the funds shares are sold only through the currently effective prospectus complete information on the needham funds including a current prospectus is available for downloading and should be read prior to making any decision to invest click here to go to the download library investment in the funds involves investment risk including the possible loss of principal please read the prospectus and consider the investment objectives risks and charges and expenses of the funds carefully before you invest the prospectus and the summary prospectus contain this and other information about the funds the results contained on this site represent past performance of the funds past performance does not guarantee future results and current performance may be higher or lower than these results performance current to the most recent monthend may be obtained by calling  the funds’ use of short sales options and futures strategies and leverage may result in significant capital loss although the fund is classified as “diversified” under the investment company act of  as amended the “ act” the fund may invest its assets in a smaller number of issuers than other more diversified funds the fund’s net asset value “nav” may be more vulnerable to changes in the market value of a single issuer or group of issuers and may be relatively more susceptible to adverse effects from any single corporate industry economic market political or regulatory occurrence than if the fund’s investments consisted of securities issued by a larger number of issuers total return figures include reinvestment of all dividends and capital gains investment returns and principal value will fluctuate and when redeemed shares may be worth more or less than their original cost shares held  days or less are subject to a shortterm redemption fee of  needham  company llc member finrasipc is the distributor of the needham funds inc these securities have not been approved or disapproved by the securities and exchange commission or any state securities commission nor has the securities and exchange commission or any state securities commission passed upon the accuracy or adequacy of this document any representation to the contrary is a criminal offense for details regarding the needham funds please contact needham investment management llc at  · needham  company llc  · needham funds  · needham capital partners  the needham group inc needham  company llc is a member of finra  sipc all rights reserved terms of use  privacy policy  business continuity plan needham capital partners  investment portfolio the needham group skip navigation home search about us investment strategy investment portfolio news contact us about us investment professionalsaffiliations investment strategy financing focuscompany evaluationindustry focusdecision processsubmit proposal investment portfolionewscontact new yorkbostonchicagomenlo parksan francisco sort by company location initial date sector fund ascending descending agile software redwood shores ca develops and markets collaborative manufacturing commerce solutions that speed the build and buy process across the virtual manufacturing network the company went public in  and has since been acquired by oracle the worlds largest business software company   software  services ncp ii alacritech inc san jose ca provides accelerator solutions that enable fast and efficient servers and storage systems   hardware  storage ncp iii athena semiconductors inc fremont ca a fabless ic company specializing in cmos radio transceiver ic products addressing rapidly growing wireless broadband communications and convergence markets   semiconductors  semiconductor equipment ncp iii atherotech inc birmingham al privately held cardiodiagnostic company focusing on direct measurement of the comprehensive lipid profile using the companys vap vertical auto profile technology   healthcare ncp ii august technology corporation bloomington mn august technology corporation designs manufactures and markets automated inspection equipment for the semiconductor industry the company went public in  and merged with rudolph technology in    semiconductors  semiconductor equipment ncp ii bay microsystems san jose ca designs and markets highperformance communications processors the company is currently private   semiconductors  semiconductor equipment ncp ii biocept inc san diego ca develops and commercializes nextgeneration microarrays for genomics and proteomics its first products focus on prenatal diagnostic testing   healthcare ncp iii blue pumpkin software incwitness systems sunnyvale ca provides workforce optimization software for the strategic planning and management of contact center personnel the company was acquired by witness systems inc nasdaq wits   software  services ncp iii boxer cross santa clara ca designs manufactures and markets leadingedge inline metrology tools for the semiconductor industry the company was acquired by applied materials amat in april    semiconductors  semiconductor equipment ncp ii capital sli group llc indianapolis in a fullservice insurance and financial services company   software  services ncp iii centerrun inc redwood city ca provides productivity applications for the enterprise data center   software  services ncp iii ceon corporationconvergys corporation redwood city ca designs and develops operation support systems oss for the telecommunications industry the company was acquired by convergys corporation nyse cvg on october   convergys is a global leader in relationship management   hardware  storage ncp ii ceradyne inc costa mesa ca leader in advanced technical ceramics that are suitable for a number of highend applications including the ceramic armored vests used by our soldiers and reporters in iraq   industrial  diversified growth ncp ii ncp iii chip x corp chip express santa clara ca manufactures fastturn prototypes and production of asics the company is currently private   semiconductors  semiconductor equipment ncp ii clarity visual systems incplanar systems beaverton or develops networkenabled display systems for retail signage and data visualization applications clarity visual systems was acquired by planar systems in september  planar went public in    business services ncp ii collectors universe newport beach ca provides authentication services on coins memorabilia stamps and other collectibles the company went public in    consumer ncp ii college enterprises incblackboard washington dc blackboard inc was acquired through an investment in college enterprises inc cei which is a holding company that owns  of blackboard on june   blackboard went public in an ipo priced at  per share   consumer ncp ii color kinetics inc burlington ma designs manufactures and markets led systems for use in professional lighting consumer and oem  licensing applications the company went public on june     semiconductors  semiconductor equipment ncp iii coventor cary nc develops and markets eda software components and professional services to the mems industry the company is currently private   software  services ncp ii ncp iii coware san jose ca develops systemonachip eda software for the semiconductor industry the company is currently private   software  services ncp ii dicarta incemptoris burlington ma designs and markets enterprise contract management solutions   software  services ncp iii displaytech inc longmont co high resolution miniature displays for projection and magnifiedview applications   semiconductors  semiconductor equipment ncp iii epartners inc irving tx installs and supports microsoftbased software for middlemarket companies providing enduser training annual systems reviews call center support onsite support and technology updates among other services   business services ncp iii fatbraincombarnesandnoblecom santa clara ca supplies online computer manuals training texts and books to technical professionals the company went public in  and was acquired by barnesandnoblecom bnbn in    consumer ncp ii favrille inc palo alto ca engaged in the research development and commercialization of targeted immunotherapies for the treatment of cancer and other diseases of the immune system favrille began trading on february   as of january   the company is known as mmr information systems inc   healthcare ncp iii hot railconexantskyworks newport beach ca a fabless semiconductor company that designs and markets scalable logic solutions for multiprocessing that address the performance bottlenecks associated with computer and dataflow intensive applications the company was acquired by conexant systems inc in    semiconductors  semiconductor equipment ncp ii innovion inc san jose ca provides ion implant services to leading semiconductor manufacturers   semiconductors  semiconductor equipment ncp ii kanisa incknova cupertino ca in march  knova launched its new identity following the merger of serviceware technologies a respected industry veteran in knowledge management for customer support and kanisa the technology pioneer of service resolution management ncp iii invested a total of m in kanisa   software  services ncp iii lara networks inc san jose ca provides broadband switching products and network application processors the company was acquired by cypress semiconductor inc in    hardware  storage ncp ii loadstar sensors inc fremont ca designs and manufactures capacitive sensors for automotive aerospace medical device and industrial applications   industrial  diversified growth ncp iii logic vision san jose ca supplies embedded systemonachip test solutions called builtinselftest bist to the semiconductor industry the company went public in october    software  services ncp ii nascentric inc austin tx develops and markets software to electrically analyze cmos integrated circuit designs   semiconductors  semiconductor equipment ncp ii neophotonics corp san jose ca manufactures optical components for every network market segment ftthaccess datacom storage area networks metro and long haul networks   hardware  storage ncp iii nextest incteradyne san jose ca develops and produces automatic test equipment for highperformance logic and memory devices for the semiconductor industry   semiconductors  semiconductor equipment ncp iii obsidianapplied materials santa clara ca obsidian develops a fixedabrasive slurryfree chemical mechanical polishing technology applied materials inc nasdaq amat is a fortune  global growth company and the worlds largest supplier of wafer fabrication systems and services to the global semiconductor industry   semiconductors  semiconductor equipment ncp ii peregrine semiconductor corp san diego ca designs and manufactures highperformance integrated circuits based on its patented commercial ultra thin silicon utsi cmos process technology the company is currently private   semiconductors  semiconductor equipment ncp ii persistence software inc san mateo ca provides application server software products that reduce inefficiencies in queryintensive applications and enable the efficient management of distributed data in large enterprises progress software inc acquired the company in september    software  services ncp iii pharsight corporation mountain view ca develops and markets information technology for managing the scientific aspects of the clinical phase of the pharmaceutical development process the company went public in    healthcare ncp ii rebar distributes integrated personal computer business software and technology services to major corporations the company was acquired by level  communications inc lvlt in    business services ncp ii sensis corporation syracuse ny a global provider of air defense air traffic control airline and airport operations management and data integration and distribution   communications ncp iii silicon metrics austin tx develops eda software products that accurately model the electrical behavior of silicon intellectual property for the semiconductor industry the company was acquired by magma design automation inc lava in    software  services ncp ii softek storage solutions inc sunnyvale ca develops software that reduces the risks costs and complexities of managing data storage in multivendor mainframe and open system environments   software  services ncp iii southwall technologies inc palo alto ca designs and produces thinfilm coatings on plastic sheets that selectively absorb reflect or transmit heat and light   industrial  diversified growth ncp ii ncp iii spaceclaim corp concord ma targets the mechanical design market and provides breakthrough technology that enhances engineers productivity by empowering them to contribute to consume and share mechanical designs in a d digital form   software  services ncp iii stanford microdevices incsirenza sunnyvale ca a fabless semiconductor company that designs and markets gallium arsenide   semiconductors  semiconductor equipment ncp ii testquest inc east minneapolis mn develops automated nonintrusive product testing for embedded systems the companys products replace laborintensive manual testing in the general computing hand held industrial control and interactive television markets   semiconductors  semiconductor equipment ncp iii trinity convergence inc durham nc privately held company focused on developing comprehensive software solutions for the emerging voip and voice  video over ip vip communications equipment market   software  services ncp iii viewlogic systems incinnoveda marlboro ma develops and markets eda software for fpga printed circuit boards and systems designs the company was acquired in a management buyout from synopsys inc in  and merged with summit designs inc smmt to form innoveda   software  services ncp ii wind river systems incrapid logic alameda ca rapid logic inc was acquired by wind river systems inc nasdaqwind on october   rapid logic is a provider of intelligent device management software that enables manufacturers of network devices to incorporate remote management capabilities into their products via the internet wind river is a worldwide leader in embedded software the acquisition valued rapid logic at approximately  million   hardware  storage ncp ii needham  company llc  needham funds  needham capital partners  the needham group inc needham  company llc is a member of finra  sipc all rights reserved terms of use  privacy policy  business continuity plan designed and developed by piehead productions llc needham  company the needham group skip navigation home search client access about us news contact us about us overviewtransaction historymanagementcareers firm culturecareer opportunitiessubmit resume september th scholarship fund institutional sales  trading overviewsalestradingmarket maker list and disclosuresteam leadershipsalestrading conferences equity research overviewcoverage universe with disclosuresteam leadershipclean technologiescommunications  enterprise infrastructurehealthcareindustrial  diversified growthinternet entertainment  consumersemiconductors  semiconductor equipmentsoftware  services equity research client login investment banking overviewcorporate finance industry focusproduct focus public equity offeringsmergers  acquisitionsprivate capital marketsspecial situations  restructurings team leadershipchina investment bankingclean technologycommunicationsenterprise infrastructurefinancial serviceshealthcareindustrial  diversified growthinternet digital media  consumerisraeli investment bankingsemiconductors  semi equipmentsoftware  servicesmergers  acquisitionsprivate capital marketscapital markets corporate  venture services corporate servicesexecutive servicesventure servicesteamformsclient access private capitaltransaction history asset managementnews needham press releasesother needham newsfor press  media contact new yorkbostonchicagomenlo parksan francisco welcome to needham needham  company llc a subsidiary of the needham group inc is a nationally recognized investment banking and asset management firm focused solely on growth companies and their investors needham’s mission is to provide its clients with the longterm advice they need to achieve their business goals the firms commitment to exceptional service is unusual in today’s business climate and is born of a tradition which stresses integrity above all else we strive to be front of mind approachable and idea driven needham is actively engaged in the public and private capital markets boasting a year track record of executing complex transactions and the accompanying reputation for excellence in our marketsneedham’s principal activities involve assisting our clients through a variety of advisory and transactionrelated services with a specific focus on public and private financings mergers acquisitions and divestitures equity research institutional sales and trading asset management through public and private funds  to check the background of our firm on finra’s brokercheck  click here adesto technologies nasdaqiots is a leading provider of applicationspecific ultralow power smart nonvolatile memory products the company has designed and built a portfolio of innovative products with intelligent features to conserve energy and enhance performance including fusion serial flash dataflash® ecoxip™ and products based on its trademark resistive ram technology called conductive bridging ram cbram® cbram® is a breakthrough technology platform that enables  times less energy consumption than today’s flash memory technologies as well as delivering enhanced performanceadesto technologies corporation raised  million in its followon offering at  per share needham acted as the sole bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by adesto technologies corporation for general corporate purposescrisp mobile has over  years’ experience in delivering marketer content via mobile devices crisp’s exclusive focus on the retail and cpg markets means that only crisp has both the deep vertical knowledge and the proven ability to activate shoppers on the device they use most often their mobile phone crisp provides the industry’s first endtoend mobile customer activation platform to deliver radically improved mobile experiences for shoppers and marketers alike these unrivaled experiences along with a proven ability to deliver results have made crisp a trusted partner to many of today’s largest retail and cpg brandscrisp mobile a mobile marketing and advertising company primarily serving cpg and retail customers completed its previously announced sale to quotient technology inc nysequot a leading digital promotions media and analytics company that connects brands retailers and shoppers for approximately  million while crisp will continue to operate as its own brand quotient will take advantage of the natural synergies as quotient expands their efforts in shopper marketing needham  company acted as exclusive financial advisor to crisp mobileupland software inc nasdaq upld is a leading provider of cloudbased enterprise work management software its family of applications enables users to manage their projects professional workforce and it investments automate documentintensive business processes and effectively engage with their customers prospects and community via the web and mobile technologies with more than  customers and over  users around the world upland solutions help customers run their operations smoothly adapt to change quickly and achieve better results every dayupland software inc raised  million in its upsized followon offering at  per share needham acted as joint bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by upland software inc for general corporate purposes general corporate purposes may include additions to working capital financing of capital expenditures repayment or redemption of existing indebtedness repurchases of stock and future acquisitions and strategic investment opportunities lendingtree inc nasdaq tree operates the nations leading online loan marketplace and provides consumers with an array of online tools and information to help them find the best loans for their needs lendingtrees online marketplace connects consumers with multiple lenders that compete for their business empowering consumers as they comparisonshop across a full suite of loans and creditbased offerings since its inception lendingtree has facilitated more than  million loan requests lendingtree provides access to its network of over  lenders offering home loans home equity loanslines of credit reverse mortgages personal loans auto loans small business loans credit cards student loans and more lendingtree inc is headquartered in charlotte nc and maintains operations solely in the united stateslendingtree inc issued  million convertible senior notes due  the notes in an upsized private placement to qualified institutional buyers pursuant to rule a under the securities act of  as amended the securities act the underwriters fully exercised their option to purchase an additional  million in aggregate principal amount of the notes to cover overallotments needham  company acted as a comanager for this transaction lendingtree inc intends to use the net proceeds from the notes offering for general corporate purposes including but not limited to working capital and potential acquisitionscorium international inc nasdaq cori is a commercialstage biopharmaceutical company focused on the development manufacture and commercialization of specialty pharmaceutical products that leverage the company’s broad experience with advanced transdermal and transmucosal delivery systems corium has multiple proprietary programs in preclinical and clinical development focusing primarily on the treatment of neurological disorders with lead programs in alzheimer’s disease corium has developed and is the sole commercial manufacturer of seven prescription drug and consumer products with partners teva pharmaceuticals endo pharmaceuticals and procter  gamble the company has two proprietary transdermal platforms corplex™ for small molecules and microcor® a biodegradable microstructure technology for small molecules and biologics including vaccines peptides and proteins the company’s latestage pipeline includes a contraceptive patch codeveloped with agile therapeutics that is currently in phase  trials and additional transdermal products that are being developed with other partnerscorium international inc raised  million in its upsized followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by corium international inc to offering for product development and general corporate purposes which may include funding research and development increasing its working capital reducing indebtedness acquisitions or investments in businesses products or technologies that are complementary to its own and capital expendituresalbireo pharma inc nasdaq albo is a clinicalstage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders albireo’s clinical pipeline includes two phase  product candidates and one phase  product candidate albireo was spun out from astrazeneca in  albireo pharma is located in boston massachusetts and its key operating subsidiary albireo ab is located in gothenburg swedenalbireo pharma inc raised  million in its upsized followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by albireo pharma inc to complete the phase  clinical program of a to treat patients with pfic to initiate a clinical trial of a in one or more additional pediatric cholestatic liver diseases to initiate a phase  clinical trial of a to treat bam to advance our preclinical program in nash and if the company select a product candidate from their nash program for clinical development to complete the preclinical development activities necessary to initiate a phase  clinical trial of the product candidate and for general corporate purposes smart global holdings nasdaq sgh the parent company of smart modular technologies inc is a global leader in specialty memory solutions serving the electronics industry for over  years and holds a leading international market position as measured by revenue in specialty memory smart global holdings inc raised  million in its initial public offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by smart global holdings inc to repay a portion of their outstanding term loans under the senior secured credit agreement in addition the company intends to use  million of the net proceeds to make a payment to affiliates of silver lake for unpaid management fees in respect of past periods under the amended and restated transaction and management fee agreement which they intend to terminate upon the completion of this offering the remaining net proceeds shall be used for general corporate purposesthe trade desk inc nasdaqttd is a technology company that empowers buyers of advertising through its selfservice cloudbased platform ad buyers can create manage and optimize more expressive datadriven digital advertising campaigns across ad formats including display video audio native and social on a multitude of devices such as computers mobile devices and connected tv integrations with major data inventory and publisher partners ensure maximum reach and decisioning capabilities and enterprise apis enable custom development on top of the platform headquartered in ventura ca the trade desk has offices across the united states europe and asiathe trade desk inc raised  million in its upsized followon offering at  per share of class a common stock by certain selling stockholders  needham acted as a comanager on the transaction the company’s underwriters exercised their option to purchase an additional  shares of class a common stock at the followon offering price to cover overallotments the trade desk will not receive any proceeds from the offering g therapeutics inc nasdaq gthx is a clinicalstage biopharmaceutical company developing novel smallmolecule therapies that address significant unmet needs in the treatment of cancer the company is advancing a pipeline of potential bestinclass and firstinclass drug candidates in multiple oncology indications g is based in research triangle park ncg therapeutics inc raised  million in its upsized initial public offering at  per share needham acted as a comanager on the transaction the company’s underwriters exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by g therapeutics inc to advance the product development of trilaciclib gt  gt and general corporate purposes including working capital and operating expensesconcurrent computer corporation nasdaqccur is a global software and solutions company that develops advanced applications focused on storing protecting transforming and delivering high value media assets we serve industries and customers that demand uncompromising performance reliability and flexibility to gain a competitive edge drive meaningful growth and confidently deliver bestinclass solutions that enrich the lives of millions of people around the world every day offices are located in north america europe and asia concurrent computer corporation nasdaq ccur a global software and solutions company that develops advanced applications focused on storing protecting transforming and delivering high value media assets completed its previously announced sale of its realtime business segment to battery ventures for  million in cash the realtime business segment will operate as an independent privatelyheld company doing business as concurrent realtime inc needham  company acted as financial advisor to concurrent computer corporationdermira inc nasdaq derm is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated new therapies to the millions of patients living with chronic skin conditions dermira is committed to understanding the needs of both patients and physicians and using its insight to identify and develop leadingedge medical dermatology programs dermira’s product pipeline includes three phase  product candidates that could have a profound impact on the lives of patients glycopyrronium tosylate in development for the treatment of primary axillary hyperhidrosis excessive underarm sweating cimzia® certolizumab pegol in development in collaboration with ucb pharma sa for the treatment of moderatetosevere chronic plaque psoriasis and olumacostat glasaretil in development for the treatment of acne vulgaris dermira is headquartered in menlo park california dermira inc issued  million aggregate principal amount of  convertible senior notes due  the “notes” in a private offering to qualified institutional buyers pursuant to the securities act of  as amended the “securities act” the underwriters fully exercised their option to purchase an additional  million in aggregate principal amount of the notes to cover overallotments needham  company acted as a comanager for this transaction dermira intends to use the net proceeds that it receives from the note offering for working capital capital expenditures and other general corporate purposes dermira may also use a portion of the net proceeds from this offering to expand its business by inlicensing or acquiring as the case may be product candidates technologies compounds other assets commercial products or complementary businessesbiohaven pharmaceutical holding company ltd nyse bhvn is a clinicalstage biopharmaceutical company with a portfolio of innovative latestage product candidates targeting neurological diseases including rare disorders biohaven has licensed intellectual property from companies and institutions including bristolmyers squibb company astrazeneca ab yale university catalent als biopharma llc and massachusetts general hospital biohaven is a company organized under the laws of the british virgin islands and its united states operations are based in new haven connecticutbiohaven pharmaceuticals holding company ltd raised  million in its initial public offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by biohaven pharmaceuticals to initiate and complete two phase  clinical trials of rimegepant for the acute treatment of migraine fund continued research and development of bhv for the prevention of chronic and episodic migraine complete ongoing phase  trial of trigriluzole for the treatment of sca fund continued research and development of bhv for the treatment of breathing irregularities associated with rett syndrome including completion of planned phase  clinical trial for this indication repay aggregate indebtedness under credit agreement with wells fargo and notes payable to related parties satisfy remaining obligation to purchase shares of capital stock of kleo pharmaceuticals and fund other research and development activities including the development of bhv for the treatment of als as well as for working capital and other general corporate purposes including the satisfaction of any milestone payment obligations under license agreementsichor holdings ltd nasdaq ichr is a leader in the design engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment our primary offerings include gas and chemical delivery subsystems collectively known as fluid delivery subsystems which are key elements of the process tools used in the manufacturing of semiconductor devices our gas delivery subsystems deliver monitor and control precise quantities of the specialized gases used in semiconductor manufacturing processes such as etch and deposition our chemical delivery subsystems precisely blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes such as electroplating and cleaning we also manufacture certain components for internal use in fluid delivery systems and for direct sales to our customers this vertically integrated portion of our business is primarily focused on metal and plastic parts that are used in gas and chemical systems respectivelyichor holdings ltd raised  million in its upsized followon offering at  per share by selling shareholders needham acted as passive bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments ichor holdings ltd will not receive any proceeds from the offeringflexion therapeutics inc nasdaq flxn is a specialty pharmaceutical company focused on the development and commercialization of novel local therapies for the treatment of patients with musculoskeletal conditions beginning with osteoarthritis oa flexions lead product candidate zilretta is being investigated for its potential to provide improved analgesic therapy for the millions of us patients who receive intraarticular injections for knee oa annuallyflexion therapeutics inc issued  million  convertible senior notes due  the notes in a private placement to qualified institutional buyers pursuant to rule a under the securities act of  as amended the securities act the underwriters fully exercised their option to purchase an additional  million in aggregate principal amount of the notes to cover overallotments needham  company acted as a comanager for this transaction flexion intends to use the net proceeds from the notes offering for the commercialization and manufacture of zilrettatm also known as fx if approved product pipeline development as well as working capital and general corporate purposes flexion may also use a portion of the net proceeds to inlicense acquire or invest in complementary businesses technologies products or assets vixs systems tsx vxs is a pioneer and market leader in designing revolutionary media processing semiconductor solutions for video over ip streaming solutions with more than  patents issued and pending worldwide numerous industry awards for innovation and over  million media processors shipped to date vixs is driving the transition to ultra hd k across the entire content value chain by providing professional and consumer grade chipsets that support the new high efficiency video coding hevc standard up to main  profile reducing bandwidth consumption by  while providing the depth of color and image clarity needed to take advantage of higherresolution content vixs’ xcodepro  family is ideal for ultra hd k infrastructure equipment and the xcode  family of systemonchip soc products achieve unprecedented levels of integration that enable manufacturers to create costeffective consumer entertainment devices vixs is headquartered in toronto canada with offices in europe asia and north america vixs™ the vixs® logo xcode® xcodepro™ and xtensiv™ are trademarks andor registered trademarks of vixs other trademarks are the property of their respective owners vixs systems tsx vxs a pioneer and leader in media processing solutions today announced that it has sold its legacy moca multimedia over coaxial alliance business to maxlinear inc nysemxl a leading provider of radio frequency rf and mixedsignal integrated circuits for cable and satellite broadband communications the connected home data center metro longhaul fiber networks and wireless infrastructure this divestiture will allow vixs to focus on its core video business strategies built around delivering bestinclass uhdhdr solutions for the consumer and video delivery market segments vixs plans to use the sale proceeds to improve its balance sheet and for working capital needed to support customers to achieve profitable growth needham  company acted as exclusive financial advisor to vixs systemssynacor nasdaq sync is the trusted technology development multiplatform services and revenue partner for video internet and communications providers device manufacturers and enterprises synacor’s mission is to enable its customers to better engage with their consumers its customers use synacor’s technology platforms and services to scale their businesses and extend their subscriber relationships synacor delivers managed portals advertising solutions email and collaboration platforms endtoend video solutions and cloudbased identity management synacor inc raised  million in its followon offering at  per share needham acted as joint bookrunner on the transaction the company’s underwriters exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by synacor inc for general corporate purposes which may include working capital capital expenditures other corporate expenses and acquisitions of complementary products technologies or businesseseverbridge inc nasdaq evbg is a global software company that provides enterprise software applications that automate and accelerate an organization’s operational response to critical events in order to keep people safe and businesses running during public safety threats such as active shooter situations terrorist attacks or severe weather conditions as well as critical business events such as it outages or cyberattacks over  global customers rely on the company’s saasbased platform to quickly and reliably aggregate and assess threat data locate people at risk and responders able to assist automate the execution of predefined communications processes and track progress on executing response plans the company’s platform sent over  billion messages in  and offers the ability to reach more than  countries and territories with secure delivery to over  different communication devices the company’s critical communications and enterprise safety applications which include mass notification incident management it alerting safety connection™ community engagement™ secure messaging visual command center and crisis commander are easytouse and deploy secure highly scalable and reliable everbridge serves  of the  largest us cities  of the  largest usbased investment banks all four of the largest global accounting firms  of the  busiest north american airports and  of the  largest global automakers everbridge is based in boston and los angeles with additional offices in san francisco lansing beijing london and stockholmeverbridge inc raised  million in its upsized followon offering consisting of both primary and secondary shares at  per share needham acted as comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by everbridge inc for for general corporate purposes including working capital and capital expenditures everbridge will not receive any proceeds from the sale of shares sold by the selling stockholders gigpeak inc nyse mktgig is a leading innovator of semiconductor ics and software solutions for highspeed connectivity and highquality video compression over the network and the cloud the focus of the company is to develop and deliver products that enable lower power consumption and faster data connectivity more efficient use of network infrastructure broader connectivity to the cloud and reduce the total cost of ownership of existing network pipes from the core to the end user gigpeak addresses both the speed of data transmission and the amount of bandwidth the data consumes within the network and provides solutions that increase the efficiency of the internet of things leveraging its strength in highspeed connectivity and highquality video compression the extended product portfolio provides more flexibility to support changing market requirements from ics and mmics through full software programmability and costefficient custom asicsgigipeak inc a manufacturer of semiconductor ics and software solutions for highspeed connectivity and highquality video compression over the network and the cloud completed its previously announced sale to integrated device technology nasdaq idti a global leader in mixed signal semiconductor solutions for the advanced communications computing and consumer industries for  per share in cash or approximately  million the acquisition of gigpeak provides idt with a highly regarded optical interconnect product and technology business that is complementary to idts leadership position in realtime interconnect products needham  company acted as a financial advisor to gigpeak incessen bioscience inc develops and manufactures instruments software reagents and consumables which enable researchers to remotely image and quantitate a wide variety of cellular processes over time the incucyte® system is a realtime quantitative livecell analysis platform that enables visualization and quantification of cell behavior over time by automatically gathering and analyzing images around the clock within a standard laboratory incubator the system allows researchers to make timelapsed fully kinetic measurements from living cells over days and weeks thus providing insight into active biological processes in real time the company was founded in ann arbor michigan in essen bioscience inc a pioneer and leader in the field of cellbased assays and instrumentation used for life sciences research completed its previously announced sale to sartorius group ag fwb srt a leading partner to the biopharmaceutical industry and laboratories for  million through this acquisition sartorius will significantly expand its portfolio for bioanalytics a field the company has recently entered via the intellicyt acquisition in  needham  company acted as a financial advisor to essen bioscience inccara therapeutics nasdaq cara is a clinicalstage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors cara is developing a novel and proprietary class of product candidates led by cr that target the bodys peripheral nervous system and have demonstrated in phase  trials preliminary efficacy in patients with moderatetosevere pain and pruritus without inducing many of the undesirable side effects typically associated with currently available pain therapeuticscara therapeutics inc raised  million in its followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by cara therapeutics inc to fund the companys clinical and research development activities including the completion of the phase  program for iv cr in uremic pruritus two phase  trials of iv cr in acute pain and a phase b trial of oral cr in osteoarthritis pain as well as for working capital and general corporate purposesanalogix semiconductor inc designs and manufactures semiconductors for the digital multimedia market from portable devices such as smartphones to highend graphics cards and large highdefinition displays analogix is the market leader in providing endtoend interface connectivity semiconductor solutions for displayport including highspeed signal conditioners and the slimport family of products and an industry leader in mobile display controllers such as lowpower highspeed timing controller solutions the displayport standard is an innovative packetized digital interface for highresolution video and audio that was developed by the video electronics standards association vesa slimport branded products are compliant with displayport mobility displayport mydp and displayport alternate mode over the usb typec connector analogix semiconductor inc a global leader in designing highperformance mixedsignal semiconductors that enable “hd everywhere” the goanywhere anymobiletoanyscreen highdefinition experience completed its previously announced sale to beijing shanhai capital management co ltd shanhai capital a pioneer buyout fund in healthcare and technology managing rmb and usddenominated funds enhanced by the strong financial support of its new investors analogix will continue building and growing the company into a global leader in highperformance semiconductors needham  company acted as a financial advisor to analogix semiconductor inccryoport inc nasdaq cyrx is the life sciences industrys most trusted global provider of cold chain logistics solutions for temperaturesensitive life sciences commodities serving the biopharmaceutical market with leadingedge logistics solutions for biologic materials such as regenerative medicine including immunotherapies stem cells and cart cells cryoports solutions are used by pointsofcare cros central laboratories pharmaceutical companies manufacturers university researchers et al as well as the reproductive medicine market primarily in ivf and surrogacy and the animal health market primarily in the areas of vaccines and reproduction cryoports proprietary cryoport express® shippers cryoportal™ logistics management platform leadingedge smartpak ii™ condition monitoring system and geosensing technology paired with unparalleled cold chain logistics expertise and  client support make cryoport the endtoend cold chain logistics partner that the industry trustscryoport inc raised  million in its followon offering at  per share needham acted as jointbookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by cryoport inc for business growth including as working capital and for other general corporate purposesevrythng is the internet of things smart products platform connecting consumer products to the web and managing realtime data to drive applications and analytics throughout the product lifecycleevrythng completed the pricing of its  million series b funding round led by san franciscobased sway ventures and also including torontobased generation ventures and londonbased bloc ventures needham acted as sole placement agent for this transaction the new investors join a strong base of existing backers including cisco investments samsung bhlp atomico dawn capital and advance vixeid partners the funding will support evrythng’s growth through partnerships the expansion of its team and continued development of its enterprisefocused iot platform for managing intelligent software identities in the cloud and digital lifecycle applications for product manufacturersaxt inc nasdaq axti designs develops manufactures and distributes highperformance compound and single element semiconductor substrates comprising indium phosphide inp gallium arsenide gaas and germanium ge through its manufacturing facilities in beijing china in addition axt maintains its sales administration and customer service functions at its headquarters in fremont california the company’s substrate products can be used primarily in fiber optic communications d sensing solar cell lighting display applications and wireless communications its vertical gradient freeze vgf technique for manufacturing semiconductor substrates provides significant benefits over other methods and enabled axt to become a leading manufacturer of such substrates axt has manufacturing facilities in china and as part of its supply chain strategy has partial ownership in ten companies in china producing raw materialsaxt technology inc raised  million in its followon offering at  per share needham acted as the sole bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by axt inc for general corporate purposes which may include the relocation of its gallium arsenide product line working capital capital expenditures and other corporate expensesdermira inc nasdaq derm is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated new therapies to the millions of patients living with chronic skin conditions dermira is committed to understanding the needs of both patients and physicians and using its insight to identify and develop leadingedge medical dermatology programs dermira’s product pipeline includes three phase  product candidates that could have a profound impact on the lives of patients glycopyrronium tosylate in development for the treatment of primary axillary hyperhidrosis excessive underarm sweating cimzia® certolizumab pegol in development in collaboration with ucb pharma sa for the treatment of moderatetosevere chronic plaque psoriasis and olumacostat glasaretil in development for the treatment of acne vulgaris dermira is headquartered in menlo park california dermira inc raised  million in its upsized followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by dermira inc for general corporate purposes which may include working capital capital expenditures other corporate expenses and acquisitions of complementary products technologies or businesses in addition it will enable ucb to submit an sbla to the fda for potential approval of cimzia complete registrationenabling activities and submit an nda to the fda for potential approval related to glycopyrronium tosylate enable the company to complete and generate topline results from their ongoing phase  pivotal clinical trials for olumacostat glasaretil commercialize their cimzia and glycopyrronium tosylate product candidates assuming that the company receives the necessary regulatory approvals complete registrationenabling activities and submit an nda to the fda for potential approval related to olumacostat glasaretil assuming the data from their phase  clinical trials are positive and commence potential lifecycle management activities related to their glycopyrronium tosylate and olumacostat glasaretil product candidates the trade desk inc nasdaqttd is a technology company that empowers buyers of advertising through its selfservice cloudbased platform ad buyers can create manage and optimize more expressive datadriven digital advertising campaigns across ad formats including display video audio native and social on a multitude of devices such as computers mobile devices and connected tv integrations with major data inventory and publisher partners ensure maximum reach and decisioning capabilities and enterprise apis enable custom development on top of the platform headquartered in ventura ca the trade desk has offices across the united states europe and asiathe trade desk inc raised  million in its upsized followon offering at  per share of class a common stock by certain selling stockholders  needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of class a common stock at the followon offering price to cover overallotments the trade desk will not receive any proceeds from the offeringathersys inc nasdaqathx is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life the company is developing its multistem® cell therapy product a patented adultderived offtheshelf stem cell product initially for disease indications in the neurological cardiovascular and inflammatory and immune disease areas and has several ongoing clinical trials evaluating this potential regenerative medicine product athersys has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology companies as well as worldrenowned research institutions to further develop its platform and productsathersys inc raised  million in its followon offering at  per share needham acted as lead manager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by athersys inc for working capital and general corporate purposes including funding towards its phase  multistem® administration for stroke treatment and enhanced recovery study masters clinical study and its other ongoing clinical programsapplied micro circuits corporation nasdaq amcc is a global leader in computing andconnectivity solutions for nextgeneration cloud infrastructure and data centers appliedmicro delivers silicon solutions that dramatically lower total cost of ownership corporate headquarters are located in sunnyvale california appliedmicro became a wholly owned subsidiary of macom on applied micro circuits corporation nasdaq amcc a global leader in computing and connectivity solutions completed its previously announced sale to macom technology solutions holdings inc nasdaq mtsi a leading supplier of highperformance rf microwave millimeterwave and lightwave semiconductor products for  million in the form of an exchange offer needham  company acted as exclusive financial advisor to applied micro circuitskornit digital nasdaq krnt develops manufactures and markets industrial digital printing technologies for the garment apparel and textile industries kornit delivers complete solutions including digital printing systems inks consumables software and aftersales support leading the digital directtogarment printing market with its exclusive ecofriendly neopigment printing process kornit caters directly to the changing needs of the textile printing value chain kornit’s technology enables innovative business models based on webtoprint ondemand and mass customization concepts with its immense experience in the directtogarment market kornit also offers a revolutionary approach to the rolltoroll textile printing industry digitally printing with a single ink set onto multiple types of fabric with no additional finishing processes founded in  kornit digital is a global company headquartered in israel with offices in the usa europe and asia pacific and serves customers in more than  countries worldwide kornit digital ltd raised  million in its upsized followon offering public offering of the  ordinary shares  of the shares are being offered by kornit and  of the shares are being offered by shareholders of the company substantially all by the company’s largest shareholder fortissimo capital fund ii israel lp at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by kornit digital for general corporate purposes the company will not receive any of the proceeds from the sale of shares being offered by the selling shareholders exablox is the company reimagining storage exablox solves businesses’ runaway storage costs and information management nightmares by providing a cloudmanaged scaleout objectbased solution that is affordable and easy to use oneblox is an inclusive storage offering that combines an elegant hardware architecture and integrated enterprisegrade software including inline deduplication continuous data protection and disaster recovery exablox’s innovative approach to storage has led to widespread customer traction across verticals including higher education healthcare insurance and the legal as well as fortune  companies as of january   exablox corporation operates as a subsidiary of storagecraft technology corporationexablox corporation the awardwinning company reimagining storage completed its sale to storagecraft the intelligent recovery and backup company storagecraft technology corporation and exablox corporation joined forces to completely focus on helping businesses analyze protect and store their data the new entity is the first company to bring together a new approach that recognizes the disappearing lines between primary and secondary storage as well as between data availability and data protection the terms of the transaction have not been publicly disclosed needham  company acted as exclusive financial advisor to exablox corporation mediafly is an enterprise software company that has worked with some of the most respected global sales organizations the mediafly evolved selling platform™ aligns with every sales training methodology and is a proven technology for helping field sales organizations deliver a dynamic interactive insightful buying experience that ties seamlessly back to crm for the third year in a row mediafly has been recognized by inc magazine as one of the top  fastestgrowing private companies in the us for more information visit wwwmediaflycommediafly a leading enterprise software company designed to help companies transform and evolve how they sell through the delivery of a perfect inperson selling experience announced the closing of a  million growth capital investment from boathouse capital this is the first outside institutional round for the company and will provide mediafly with a financial partner to support industry leading product innovation to meet the growing demand for more effective sales tools from organizations around the world as part of the transaction andy jang vice president at boathouse capital will be joining mediaflys board of directors needham  company acted as exclusive financial advisor to mediafly on this transactionichor holdings ltd nasdaq ichr is a leader in the design engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment our primary offerings include gas and chemical delivery subsystems collectively known as fluid delivery subsystems which are key elements of the process tools used in the manufacturing of semiconductor devices our gas delivery subsystems deliver monitor and control precise quantities of the specialized gases used in semiconductor manufacturing processes such as etch and deposition our chemical delivery subsystems precisely blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes such as electroplating and cleaning we also manufacture certain components for internal use in fluid delivery systems and for direct sales to our customers this vertically integrated portion of our business is primarily focused on metal and plastic parts that are used in gas and chemical systems respectively ichor holdings ltd raised  million in its initial public offering at  per share needham acted as a passive bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by ichor holdings to repay outstanding borrowings under their credit facilities and the remainder for general corporate purposes including funding working capital operating expenses and the selective pursuit of business development opportunities in their focus segment areas impinj nasdaqpi is a leading provider of rain rfid solutions the impinj platform connects billions of everyday items such as apparel medical supplies automobile parts drivers’ licenses food and luggage to applications such as inventory management patient safety asset tracking and item authentication delivering realtime information to businesses about items they create manage transport and sell the impinj platform wirelessly delivers information about these items’ unique identity location and authenticity or item intelligence™ to the digital world which impinj believes is the essence of the internet of thingsimpinj inc raised  million in its followon offering at  per share needham acted as lead manager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the number of shares sold in the offering included  shares sold by impinj and  shares sold by certain selling stockholders the net proceeds from the sale of the shares from the offering will be used by impinj inc for general corporate purposes which may include working capital capital expenditures other corporate expenses and acquisitions of complementary products technologies or businesses impinj did not receive any proceeds from the sale of the shares by the selling stockholdersttm technologies inc nasdaq ttmi is a major global printed circuit board manufacturer focusing on quickturn and technologically advanced pcbs backplane assemblies and electromechanical solutions ttm stands for timetomarket representing how ttms timecritical onestop manufacturing services enable customers to shorten the time required to develop new products and bring them to marketttm technologies inc raised  million in its followon offering of  shares of its common stock by its largest stockholder su sih bvi ltd the “selling stockholder” at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments from the selling stockholder the selling stockholder will receive all of the proceeds from the offering msp corporation is an instrumentation and equipment company creating products for scientific research and industrial applications they are known worldwide for their expertise in micro and nanoparticles and their creative use in research and manufacturing msp is the world leader in cascade impactor technology with products serving the pharmaceutical and aerosol research markets as well nanoparticle generation and measurement technology serving the semiconductor device fabrication market the company offers products through its distribution network worldwide msp corporation was incorporated in  and is based in shoreview minnesota as of november   msp corporation operates as a subsidiary of tsi incorporatedmsp group an instrumentation and equipment company with an expertise in micro and nanoparticles and their creative use in research and manufacturing completed its sale to tsi incorporated an industry leader in the design and production of precision instruments for measurements relating to aerosol science air flow health and safety indoor air quality fluid dynamics and biohazard detection the terms of the transaction have not been publicly disclosed needham  company acted as exclusive financial advisor to msp groupthe chinese consortium of investors was comprised of beijingbased ic design and solutions manufacturer chipone technology co ltd chipone and its financial partner beijing etown international investment  development co ltd etown capital it focuses on technology media and telecommunications clean technology semiconductors and modern information service industry a chinese consortium comprised of beijingbased ic design and solutions manufacturer chipone technology co ltd chipone and its financial partner beijing etown international investment  development co ltd etown capital announced that it has completed the acquisition of the integrated memory logic limited iml subsidiary of exar corporation nyse exar a leading supplier of analog mixedsignal semiconductor components and system solutions serving the industrial highend consumer and infrastructure markets for a net purchase price of  million in cash needham  company acted as exclusive financial advisor to the chinese consortium lavante inc designs and develops a cloudbased supplier information management sim and profit recovery system for fortune  companies the company offers lavante sim a transformational tool to manage and validate supplier profile automatically lavante recovery an ondemand recovery auditing solution and lavante connect a platform for connecting companies and suppliers it serves hospitality retail entertainment manufacturing and medical industries the company was formerly known as auditsolutions inc and changed its name to lavante inc in april  lavante inc was founded in  and is based in san jose california as of october   lavante inc operates as a subsidiary of prgx usa inclavante inc a saasbased procuretopay pp supplier information management sim and recovery audit services firm completed its sale to prgx global inc nasdaq prgx a global leader in recovery audit and spend analytics services the terms of the transaction have not been publicly disclosed needham  company acted as exclusive financial advisor to lavante inctheravance biopharma inc nasdaq tbph is a diversified biopharmaceutical company with the core purpose of creating medicines that help improve the lives of patients suffering from serious illness our pipeline of internally discovered product candidates includes potential bestinclass medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting vibativ® telavancin our first commercial product is a oncedaily dualmechanism antibiotic approved in the us europe and certain other countries for certain difficulttotreat infections revefenacin td is a longacting muscarinic antagonist lama being developed as a potential oncedaily nebulized treatment for chronic obstructive pulmonary disease copd our neprilysin nep inhibitor program is designed to develop selective nep inhibitors for the treatment of a range of major cardiovascular and renal diseases including acute and chronic heart failure hypertension and chronic kidney diseases such as diabetic nephropathy our research efforts are focused in the areas of inflammation and immunology with the goal of designing medicines that provide targeted drug delivery to tissues in the lung and gastrointestinal tract in order to maximize patient benefit and minimize risk the first program to emerge from this research is designed to develop intestinally restricted panjanus kinase jak inhibitors for the treatment of a range of inflammatory intestinal diseases in addition we have an economic interest in future payments that may be made by glaxo group limited or one of its affiliates gsk pursuant to its agreements with innoviva inc relating to certain drug development programs including the closed triple the combination of fluticasone furoate umeclidinium and vilanterol currently in development for the treatment of copd and asthma for more information please visit wwwtheravancecomtheravance biopharma inc raised  million in its followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by theravance biopharma inc for general corporate purposes which may include among other things research activities preclinical and clinical development of product candidates manufacture of preclinical clinical and commercial drug supplies selling and marketing expenses capital expenditures working capital general and administrative expenses and acquisitions of technology or drug candidatestheravance biopharma inc nasdaq tbph is a diversified biopharmaceutical company with the core purpose of creating medicines that help improve the lives of patients suffering from serious illness our pipeline of internally discovered product candidates includes potential bestinclass medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting vibativ® telavancin our first commercial product is a oncedaily dualmechanism antibiotic approved in the us europe and certain other countries for certain difficulttotreat infections revefenacin td is a longacting muscarinic antagonist lama being developed as a potential oncedaily nebulized treatment for chronic obstructive pulmonary disease copd our neprilysin nep inhibitor program is designed to develop selective nep inhibitors for the treatment of a range of major cardiovascular and renal diseases including acute and chronic heart failure hypertension and chronic kidney diseases such as diabetic nephropathy our research efforts are focused in the areas of inflammation and immunology with the goal of designing medicines that provide targeted drug delivery to tissues in the lung and gastrointestinal tract in order to maximize patient benefit and minimize risk the first program to emerge from this research is designed to develop intestinally restricted panjanus kinase jak inhibitors for the treatment of a range of inflammatory intestinal diseases in addition we have an economic interest in future payments that may be made by glaxo group limited or one of its affiliates gsk pursuant to its agreements with innoviva inc relating to certain drug development programs including the closed triple the combination of fluticasone furoate umeclidinium and vilanterol currently in development for the treatment of copd and asthma for more information please visit wwwtheravancecomtheravance biopharma inc issued  million principal amount of convertible senior notes due  the notes will be general unsecured obligations of the company and will pay interest semiannually on may  and november  of each year at a rate of  per year the initial conversion rate of the notes is  ordinary shares per  principal amount of the notes which is equivalent to an initial conversion price of approximately  per share and will be subject to adjustment upon the occurrence of certain events the initial conversion price represents a conversion premium of approximately  over the sale price of ordinary shares sold in the shares offering the notes will mature on november   unless earlier repurchased or converted the notes will be convertible into ordinary shares of the company at the thenapplicable conversion rate until the close of business on the second business day immediately preceding the stated maturity date the notes will not be redeemable at the companys option prior to maturity except in connection with certain changes in tax laws holders of the notes will have the right to require the company to repurchase all or any portion of their notes at  of their principal amount plus any accrued and unpaid interest upon the occurrence of certain fundamental change events the underwriters fully exercised their option to purchase an additional  million in aggregate principal amount of debentures to cover overallotments needham  company acted as a comanager for this transaction the company intends to use the net proceeds of the offerings for general corporate purposes which may include among other things research activities preclinical and clinical development of product candidates manufacture of preclinical clinical and commercial drug supplies selling and marketing expenses capital expenditures working capital general and administrative expenses and acquisitions of technology or drug candidatesquantenna communications inc nasdaq qnta is a provider of highperformance wifi solutions quantenna’s solutions combine semiconductor architecture with systemlevel software and cloud analytics with the goal of delivering the highest speed broadest coverage highest capacity and most reliable performance quantenna’s solutions primarily serve the nonmobile device market quantenna communications inc raised  million in its initial public offering at  per share needham acted as a comanager on the transaction the company’s underwriters exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by quantenna communications for general corporate purposes including working capital operating expenses and capital expenditures the company may also use a portion of the net proceeds to acquire complementary businesses products services or technologies collegium pharmaceutical inc nasdaqcoll is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patentprotected deterx technology platform for the treatment of chronic pain the deterx oral drug delivery technology is designed to provide extendedrelease delivery unique abusedeterrent properties and flexible dose administration optionscollegium pharmaceutical inc raised  million in its followon offering at  per share needham acted as a colead manager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by collegium pharmaceutical inc for the continued commercialization of xtampza funding research and development efforts of its other product candidates and working capital and general corporate purposes which may include the acquisition or licensing of product candidates technologies compounds other assets or complementary businesseseverspin technologies nasdaq mram is the leading provider of mram solutions everspin’s mram solutions offer the persistence of nonvolatile memory with the speed and endurance of random access memory ram and enable the protection of mission critical data particularly in the event of power interruption or failure everspin’s mram solutions allow its customers in the industrial automotive and transportation and enterprise storage markets to design high performance power efficient and reliable systems without the need for bulky batteries or capacitors everspin is the only provider of commercially available mram solutions and over the past eight years has shipped over  million mram units for more information visit wwweverspincomeverspin technologies raised  million in its initial public offering at  per share needham acted as a jointbookrunner on the transaction the net proceeds from the sale of the shares will be used by everspin technologies for are to obtain additional capital to create a public market for our common stock and to facilitate future access to the public equity markets the company expects to use the net proceeds received from this offering for working capital and other general corporate purposes including an estimated payment of  million due to globalfoundries in december  research and development activities sales and marketing activities and capital expenditures to enhance existing and develop new products expand our manufacturing capabilities and to fund growth acacia communications nasdaq acia develops manufactures and sells highspeed coherent optical interconnect products that are designed to transform communications networks through improvements in performance capacity and cost by converting optical interconnect technology to a siliconbased technology a process acacia refers to as the “siliconization of optical interconnect” acacia is able to offer products that meet the needs of cloud and service provider customers in a simple open highperformance form factor that can be easily integrated in a costeffective manner with existing network equipmentacacia communications inc raised  million in its followon offering at  per share the offering consists of  shares from acacia communications and  shares from certain existing stockholders needham acted as a comanager on the transaction the net proceeds from the sale of the shares from the offering will be used by acacia communications inc for working capital and general corporate purposes acacia communications will not receive any of the proceeds from any sale of shares by the selling stockholdersnutanix inc nasdaq ntnx makes infrastructure invisible elevating it to focus on the applications and services that power their business the nutanix enterprise cloud platform leverages webscale engineering and consumergrade design to natively converge compute virtualization and storage into a resilient softwaredefined solution with rich machine intelligence the result is predictable performance cloudlike infrastructure consumption robust security and seamless application mobility for a broad range of enterprise applications nutanix inc raised  million in its upsized initial public offering of class a common stock at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by nutanix inc for general corporate purposes including working capital sales and marketing activities research and development and general and administrative matterssarepta therapeutics nasdaq srpt is a biopharmaceutical company focused on the discovery and development of unique rnatargeted therapeutics for the treatment of rare neuromuscular diseases the company is primarily focused on rapidly advancing the development of its potentially diseasemodifying dmd drug candidates including exondys  designed to skip exon  and approved under the accelerated approval pathway sarepta therapeutics inc raised  million in its followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by sarepta therapeutics inc principally for the continuation and initiation of further clinical trials commercialization manufacturing business development activities including the potential licensing or acquisition of complementary products and technologies and other general corporate purposesoclaro inc nasdaq oclr is a leader in optical components modules and subsystems for the core optical enterprise and data center markets leveraging more than three decades of laser technology innovation photonics integration and subsystem design oclaros solutions are at the heart of the fast optical networks and highspeed interconnects driving the next wave of streaming video cloud computing voice over ip and other bandwidthintensive and highspeed applicationsoclaro inc raised  million in its upsized followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by oclaro inc for general corporate purposes including working capital capital expenditures other corporate expenses and acquisitions of complementary products technologies or businesses the trade desk inc nasdaq ttd is a technology company that empowers buyers of advertising through its selfservice cloudbased platform ad buyers can create manage and optimize more expressive datadriven digital advertising campaigns across ad formats including display video audio native and social on a multitude of devices such as computers mobile devices and connected tv integrations with major data inventory and publisher partners ensure maximum reach and decisioning capabilities and enterprise apis enable custom development on top of the platform headquartered in ventura ca the trade desk has offices across the united states europe and asia the trade desk inc raised  million in its initial public offering of its class a common stock at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the trade desk will not receive any proceeds from the sale of shares by the selling stockholdersaquinox pharmaceuticals inc aquinox nasdaqaqxp is a clinicalstage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immunooncology aquinoxs lead drug candidate aqx is a small molecule activator of ship suitable for oral once daily dosing with a successful phase  clinical trial completed in  aquinox initiated a phase  trial in  leadership  with aqx for treatment of icbps aquinox has a broad intellectual property portfolio and pipeline of preclinical drug candidates that activate shipaquinox pharmaceuticals inc raised  million in its followon offering at  per share needham acted as a lead manager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by aquinox pharmaceuticals inc to fund additional clinical development of aqx and to fund precommercial and market assessment activities research and development costs to advance its pipeline of preclinical product candidates and for working capital and other general corporate purposesdfmsim provides advanced enabling software solutions to the global semiconductor industry the companys technology simulates key ic design and processing steps to quickly find and avoid systemic defects that threaten yields and increase manufacturing costs dfmsims solutions are versatile modular easy to use and can be rapidly configured for various manufacturing processes and tools headquartered in silicon valley the company maintains rd sales and support offices in multiple global locationsdfmsim inc a leader in chip simulation technology completed its sale to applied materials nasdaq amat the global leader in providing innovative equipment services and software to enable the manufacture of advanced semiconductor flat panel display and solar photovoltaic products the terms of the transaction have not been publicly disclosed needham  company acted as the exclusive financial advisor to dfmsim incinphi corporation nyse iphi is a leader in highspeed data movement we move big data  fast throughout the globe between data centers and inside data centers inphis expertise in signal integrity results in reliable data delivery at high speeds over a variety of distances as data volumes ramp exponentially due to video streaming social media cloudbased services and wireless infrastructure the need for speed has never been greater thats where we come in customers rely on inphis solutions to develop and build out the service provider and cloud infrastructures and data centers of tomorrowinphi corporation issued  million principal amount of convertible senior notes due  in an upsized transaction to qualified institutional buyers pursuant to an exemption from the registration requirements of the securities act of  as amended the “securities act” inphi will settle conversions of the notes by paying or delivering as the case may be cash shares of its common stock or a combination of cash and shares of its common stock at its election in addition holders may require inphi to repurchase their notes upon the occurrence of a fundamental change as defined in the indenture governing the notes at a purchase price equal to the principal amount thereof plus accrued and unpaid interest to but excluding the repurchase date the underwriters fully exercised their option to purchase an additional  million in aggregate principal amount of notes to cover overallotments needham  company acted as a comanager for this transaction inphi intends to use a portion of the net proceeds from the offering of the notes to pay the cost of certain capped call transactions inphi intends to use the remainder of the net proceeds from the offering of the notes for general corporate purposes including financing potential acquisitions and other strategic transactionsemc corporation nyseemc is a global leader in enabling businesses and service providers to transform their operations and deliver it as a service fundamental to this transformation is cloud computing through innovative products and services emc accelerates the journey to cloud computing helping it departments to store manage protect and analyze their most valuable asset – information – in a more agile trusted and costefficient way emc corporation nyse emc a global leader in enabling businesses and service providers to transform their operations and deliver it as a service completed its historic previously announced sale to dell technologies creating a unique family of businesses that provides the essential infrastructure for organizations to build their digital future transform it and protect their most important asset information this combination creates a  billion market leader with an expansive technology portfolio that solves complex problems for customers in the industry’s fastgrowing areas of hybrid cloud softwaredefined data center converged infrastructure platformasaservice data analytics mobility and cybersecurity under the terms of the transaction emc shareholders received  per share in cash in addition to tracking stock linked to a portion of emc’s economic interest in the vmware business based on the estimated number of emc shares outstanding at close emc shareholders received  shares of new tracking stock nyse dvmt for each emc share it is the largest technology transaction on record and dell technologies now becomes the world’s largest privatelycontrolled technology company needham  company acted as a financial advisor to emc on this transaction galvanize is a dynamic tech learning community that offers education workspace and networking for students startups and large companies galvanize teaches web development data science and data engineering to students offers support and workspace to over  member companies and provides over  networking events across nine urban campuses throughout the nation galvanize campuses bring together entrepreneurs students investors mentors and great people and companies to develop the skills mindset and networks necessary to thrive in a technology driven world galvanize inc a market leader delivering technology education programs and community workspaces announced a  million series b investment led by abs capital partners a leading latestage growth company investor colorado impact fund haystack partners greg maffei aspen grove capital and existing investor university ventures also participated needham acted as financial advisor and sole agent to galvanize on this transaction the funding will be used to provide more students access to galvanize’s modern web development and data science programs and directly address employer’s needs to reskill existing employees as a result of the financing paul mariani a general partner with abs capital will join the galvanize board of directorsacadia pharmaceuticals inc nasdaq acad is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disordersacadia pharmaceuticals inc raised  million in its followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by acadia pharmaceuticals inc for to fund commercialization efforts for nuplazid ongoing and new clinical trials and development efforts for pimavanserin and for general corporate purposes which may include research development and commercialization expenses capital expenditures working capital and sales general and administrative expenses the company may also use a portion of the net proceeds to acquire or invest in complementary businesses products and technologiesdigimarc corporation nasdaq dmrc based in beaverton oregon is the inventor of the digimarc discover® platform featuring the imperceptible digimarc barcode for automatically identifying and interacting with virtually any media digimarc owns an extensive intellectual property portfolio with patents in digital watermarking content identification and management media object discovery and intuitive computing more generally digimarc inc raised  million in its upsized followon offering at  per share needham acted as the joint bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by digimarc inc for for general working capital purposes as well as to accelerate the company’s growth initiatives these growth initiatives include increasing sales marketing and operations resources for global expansion supporting a growing supplier network and feasibility and pilot projects with prospective customers continuing development of tools and processes to support efficient effective and timely implementation of its technology and further research and intellectual property development unboundid provides the industry’s leading software platform for customer identity and access management enterprise customers select the unboundid platform to modernize traditional identity and access management systems and enable new customerfacing digital business initiatives that provide realtime personalization and delivery of a consistent customer experience across channels and devices some of the world’s largest and most demanding companies in financial services retail hospitality telecommunications and healthcare rely on unboundid to manage and protect their identity and preference data across application portfolios and systems of engagement unboundid customers consistently report a total cost of ownership savings between  to  percent relative to legacy directory servers and the company enjoys a  customer renewal rate unboundid a market leading provider of customer identity and access management software to help enterprises improve customer engagement completed its sale to ping identity the leader in identity defined security terms of the transaction were not disclosed the deal puts ping identity which is owned by vista equity partners firmly in at the intersection of identity and customer engagement and management the combined company provides identity and access management solutions for the world’s leading companies including over half of the fortune  and manages over  billion identities needham  company acted as the exclusive financial advisor to unboundidellie mae inc nyseelli is a leading provider of innovative ondemand software solutions and services for the residential mortgage industry mortgage lenders of all sizes use ellie mae’s encompass® allinone mortgage management solution mavent compliance service and allregs research reference and education resources to improve compliance loan quality and efficiency across the entire mortgage lifecycleellie mae inc raised  million in its followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by ellie mae inc for general corporate purposes which may include working capital capital expenditures other corporate expenses and acquisitions of complementary products technologies or businessesargos therapeutics nasdaq args is an immunooncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases using its arcelis® technology platform argos most advanced product candidate ags is being evaluated in the pivotal adapt phase  clinical trial for the treatment of metastatic renal cell carcinoma mrcc in addition ags is being studied in phase  investigatorinitiated clinical trials as neoadjuvant therapy for renal cell carcinoma rcc and for the treatment of nonsmall cell lung cancer nsclc argos is also developing a separate arcelis®based product candidate ags for the treatment of human immunodeficiency virus hiv which is currently being evaluated in an investigatorinitiated phase  clinical trial aimed at hiv eradication in adult patientsargos therapeutics inc raised  million in its followon offering at  per share of common stock and accompanying warrants  needham acted as the lead manager on the transaction the net proceeds from the sale of the shares from the offering will be used by argos therapeutics inc to fund their pivotal phase  adapt trial of ags the ongoing and planned investigatorinitiated phase  clinical trials of ags their share of the expected costs of the leasing buildout and equipping of a commercial manufacturing facility and activities in preparation for the submission of a bla to the fda for ags and for working capital and other general corporate purposes nicox bloomberg coxfp reuters ncoxpa is an international ophthalmic rd company aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the worldnicox sa completed the pricing of an offering a reserved capital increase of ordinary shares of the company to a specific category of investors the gross proceeds of the financing are approximately € million for a total of  million new shares needham acted as lead placement agent for this transaction the net proceeds from the sale of the units will be used by nicox sa for clinical development of pipeline candidates ncx  in blepharitis and ncx  in glaucoma working capital and general corporate purposesimpinj nasdaq pi is a leading provider of rain rfid solutions the impinj platform connects billions of everyday items such as apparel medical supplies automobile parts drivers’ licenses food and luggage to applications such as inventory management patient safety asset tracking and item authentication delivering realtime information to businesses about items they create manage transport and sell the impinj platform wirelessly delivers information about these items’ unique identity location and authenticity or item intelligence™ to the digital world which impinj believes is the essence of the internet of things impinj inc raised  million in its upsized initial public offering at  per share needham acted as a lead manager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by impinj inc to repay  million of indebtedness under the mezzanine credit facility and the remainder will be used for working capital and other general corporate purposesformfactor inc nasdaq form helps semiconductor manufacturers test the integrated circuits ics that power consumer mobile devices as well as computing automotive and other applications the company is one of the world’s leading providers of essential wafer test technologies and expertise with an extensive portfolio of highperformance probe cards for dram flash and soc devices customers use formfactor’s products and services to lower overall production costs improve their yields and enable complex nextgeneration ics headquartered in livermore california the company services its customers from a network of facilities in europe asia and north americaformfactor inc nasdaqform announced that it has completed the acquisition of cascade microtech inc nasdaq cscda worldwide leader in precision contact electrical measurement and test of integrated circuits ics optical devices and other small structures for a net purchase price of  million in cash and stock needham  company acted as the exclusive financial advisor and provided a fairness opinion to the board of directors of formfactor inc as part of its services adesto technologies nasdaqiots is a leading provider of applicationspecific ultralow power smart nonvolatile memory products the company has designed and built a portfolio of innovative products with intelligent features to conserve energy and enhance performance including fusion serial flash dataflash® ecoxip™ and products based on its trademark resistive ram technology called conductive bridging ram cbram® cbram® is a breakthrough technology platform that enables  times less energy consumption than today’s flash memory technologies as well as delivering enhanced performanceadesto technologies corporation raised  million in its followon offering at  per share needham acted as the sole bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by adesto technologies corporation for general corporate purposescrisp mobile has over  years’ experience in delivering marketer content via mobile devices crisp’s exclusive focus on the retail and cpg markets means that only crisp has both the deep vertical knowledge and the proven ability to activate shoppers on the device they use most often their mobile phone crisp provides the industry’s first endtoend mobile customer activation platform to deliver radically improved mobile experiences for shoppers and marketers alike these unrivaled experiences along with a proven ability to deliver results have made crisp a trusted partner to many of today’s largest retail and cpg brandscrisp mobile a mobile marketing and advertising company primarily serving cpg and retail customers completed its previously announced sale to quotient technology inc nysequot a leading digital promotions media and analytics company that connects brands retailers and shoppers for approximately  million while crisp will continue to operate as its own brand quotient will take advantage of the natural synergies as quotient expands their efforts in shopper marketing needham  company acted as exclusive financial advisor to crisp mobileupland software inc nasdaq upld is a leading provider of cloudbased enterprise work management software its family of applications enables users to manage their projects professional workforce and it investments automate documentintensive business processes and effectively engage with their customers prospects and community via the web and mobile technologies with more than  customers and over  users around the world upland solutions help customers run their operations smoothly adapt to change quickly and achieve better results every dayupland software inc raised  million in its upsized followon offering at  per share needham acted as joint bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by upland software inc for general corporate purposes general corporate purposes may include additions to working capital financing of capital expenditures repayment or redemption of existing indebtedness repurchases of stock and future acquisitions and strategic investment opportunities lendingtree inc nasdaq tree operates the nations leading online loan marketplace and provides consumers with an array of online tools and information to help them find the best loans for their needs lendingtrees online marketplace connects consumers with multiple lenders that compete for their business empowering consumers as they comparisonshop across a full suite of loans and creditbased offerings since its inception lendingtree has facilitated more than  million loan requests lendingtree provides access to its network of over  lenders offering home loans home equity loanslines of credit reverse mortgages personal loans auto loans small business loans credit cards student loans and more lendingtree inc is headquartered in charlotte nc and maintains operations solely in the united stateslendingtree inc issued  million convertible senior notes due  the notes in an upsized private placement to qualified institutional buyers pursuant to rule a under the securities act of  as amended the securities act the underwriters fully exercised their option to purchase an additional  million in aggregate principal amount of the notes to cover overallotments needham  company acted as a comanager for this transaction lendingtree inc intends to use the net proceeds from the notes offering for general corporate purposes including but not limited to working capital and potential acquisitionscorium international inc nasdaq cori is a commercialstage biopharmaceutical company focused on the development manufacture and commercialization of specialty pharmaceutical products that leverage the company’s broad experience with advanced transdermal and transmucosal delivery systems corium has multiple proprietary programs in preclinical and clinical development focusing primarily on the treatment of neurological disorders with lead programs in alzheimer’s disease corium has developed and is the sole commercial manufacturer of seven prescription drug and consumer products with partners teva pharmaceuticals endo pharmaceuticals and procter  gamble the company has two proprietary transdermal platforms corplex™ for small molecules and microcor® a biodegradable microstructure technology for small molecules and biologics including vaccines peptides and proteins the company’s latestage pipeline includes a contraceptive patch codeveloped with agile therapeutics that is currently in phase  trials and additional transdermal products that are being developed with other partnerscorium international inc raised  million in its upsized followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by corium international inc to offering for product development and general corporate purposes which may include funding research and development increasing its working capital reducing indebtedness acquisitions or investments in businesses products or technologies that are complementary to its own and capital expendituresalbireo pharma inc nasdaq albo is a clinicalstage biopharmaceutical company focused through its operating subsidiary on the development of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders albireo’s clinical pipeline includes two phase  product candidates and one phase  product candidate albireo was spun out from astrazeneca in  albireo pharma is located in boston massachusetts and its key operating subsidiary albireo ab is located in gothenburg swedenalbireo pharma inc raised  million in its upsized followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by albireo pharma inc to complete the phase  clinical program of a to treat patients with pfic to initiate a clinical trial of a in one or more additional pediatric cholestatic liver diseases to initiate a phase  clinical trial of a to treat bam to advance our preclinical program in nash and if the company select a product candidate from their nash program for clinical development to complete the preclinical development activities necessary to initiate a phase  clinical trial of the product candidate and for general corporate purposes smart global holdings nasdaq sgh the parent company of smart modular technologies inc is a global leader in specialty memory solutions serving the electronics industry for over  years and holds a leading international market position as measured by revenue in specialty memory smart global holdings inc raised  million in its initial public offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by smart global holdings inc to repay a portion of their outstanding term loans under the senior secured credit agreement in addition the company intends to use  million of the net proceeds to make a payment to affiliates of silver lake for unpaid management fees in respect of past periods under the amended and restated transaction and management fee agreement which they intend to terminate upon the completion of this offering the remaining net proceeds shall be used for general corporate purposesthe trade desk inc nasdaqttd is a technology company that empowers buyers of advertising through its selfservice cloudbased platform ad buyers can create manage and optimize more expressive datadriven digital advertising campaigns across ad formats including display video audio native and social on a multitude of devices such as computers mobile devices and connected tv integrations with major data inventory and publisher partners ensure maximum reach and decisioning capabilities and enterprise apis enable custom development on top of the platform headquartered in ventura ca the trade desk has offices across the united states europe and asiathe trade desk inc raised  million in its upsized followon offering at  per share of class a common stock by certain selling stockholders  needham acted as a comanager on the transaction the company’s underwriters exercised their option to purchase an additional  shares of class a common stock at the followon offering price to cover overallotments the trade desk will not receive any proceeds from the offering g therapeutics inc nasdaq gthx is a clinicalstage biopharmaceutical company developing novel smallmolecule therapies that address significant unmet needs in the treatment of cancer the company is advancing a pipeline of potential bestinclass and firstinclass drug candidates in multiple oncology indications g is based in research triangle park ncg therapeutics inc raised  million in its upsized initial public offering at  per share needham acted as a comanager on the transaction the company’s underwriters exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by g therapeutics inc to advance the product development of trilaciclib gt  gt and general corporate purposes including working capital and operating expensesconcurrent computer corporation nasdaqccur is a global software and solutions company that develops advanced applications focused on storing protecting transforming and delivering high value media assets we serve industries and customers that demand uncompromising performance reliability and flexibility to gain a competitive edge drive meaningful growth and confidently deliver bestinclass solutions that enrich the lives of millions of people around the world every day offices are located in north america europe and asia concurrent computer corporation nasdaq ccur a global software and solutions company that develops advanced applications focused on storing protecting transforming and delivering high value media assets completed its previously announced sale of its realtime business segment to battery ventures for  million in cash the realtime business segment will operate as an independent privatelyheld company doing business as concurrent realtime inc needham  company acted as financial advisor to concurrent computer corporationdermira inc nasdaq derm is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated new therapies to the millions of patients living with chronic skin conditions dermira is committed to understanding the needs of both patients and physicians and using its insight to identify and develop leadingedge medical dermatology programs dermira’s product pipeline includes three phase  product candidates that could have a profound impact on the lives of patients glycopyrronium tosylate in development for the treatment of primary axillary hyperhidrosis excessive underarm sweating cimzia® certolizumab pegol in development in collaboration with ucb pharma sa for the treatment of moderatetosevere chronic plaque psoriasis and olumacostat glasaretil in development for the treatment of acne vulgaris dermira is headquartered in menlo park california dermira inc issued  million aggregate principal amount of  convertible senior notes due  the “notes” in a private offering to qualified institutional buyers pursuant to the securities act of  as amended the “securities act” the underwriters fully exercised their option to purchase an additional  million in aggregate principal amount of the notes to cover overallotments needham  company acted as a comanager for this transaction dermira intends to use the net proceeds that it receives from the note offering for working capital capital expenditures and other general corporate purposes dermira may also use a portion of the net proceeds from this offering to expand its business by inlicensing or acquiring as the case may be product candidates technologies compounds other assets commercial products or complementary businessesbiohaven pharmaceutical holding company ltd nyse bhvn is a clinicalstage biopharmaceutical company with a portfolio of innovative latestage product candidates targeting neurological diseases including rare disorders biohaven has licensed intellectual property from companies and institutions including bristolmyers squibb company astrazeneca ab yale university catalent als biopharma llc and massachusetts general hospital biohaven is a company organized under the laws of the british virgin islands and its united states operations are based in new haven connecticutbiohaven pharmaceuticals holding company ltd raised  million in its initial public offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by biohaven pharmaceuticals to initiate and complete two phase  clinical trials of rimegepant for the acute treatment of migraine fund continued research and development of bhv for the prevention of chronic and episodic migraine complete ongoing phase  trial of trigriluzole for the treatment of sca fund continued research and development of bhv for the treatment of breathing irregularities associated with rett syndrome including completion of planned phase  clinical trial for this indication repay aggregate indebtedness under credit agreement with wells fargo and notes payable to related parties satisfy remaining obligation to purchase shares of capital stock of kleo pharmaceuticals and fund other research and development activities including the development of bhv for the treatment of als as well as for working capital and other general corporate purposes including the satisfaction of any milestone payment obligations under license agreementsichor holdings ltd nasdaq ichr is a leader in the design engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment our primary offerings include gas and chemical delivery subsystems collectively known as fluid delivery subsystems which are key elements of the process tools used in the manufacturing of semiconductor devices our gas delivery subsystems deliver monitor and control precise quantities of the specialized gases used in semiconductor manufacturing processes such as etch and deposition our chemical delivery subsystems precisely blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes such as electroplating and cleaning we also manufacture certain components for internal use in fluid delivery systems and for direct sales to our customers this vertically integrated portion of our business is primarily focused on metal and plastic parts that are used in gas and chemical systems respectivelyichor holdings ltd raised  million in its upsized followon offering at  per share by selling shareholders needham acted as passive bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments ichor holdings ltd will not receive any proceeds from the offeringflexion therapeutics inc nasdaq flxn is a specialty pharmaceutical company focused on the development and commercialization of novel local therapies for the treatment of patients with musculoskeletal conditions beginning with osteoarthritis oa flexions lead product candidate zilretta is being investigated for its potential to provide improved analgesic therapy for the millions of us patients who receive intraarticular injections for knee oa annuallyflexion therapeutics inc issued  million  convertible senior notes due  the notes in a private placement to qualified institutional buyers pursuant to rule a under the securities act of  as amended the securities act the underwriters fully exercised their option to purchase an additional  million in aggregate principal amount of the notes to cover overallotments needham  company acted as a comanager for this transaction flexion intends to use the net proceeds from the notes offering for the commercialization and manufacture of zilrettatm also known as fx if approved product pipeline development as well as working capital and general corporate purposes flexion may also use a portion of the net proceeds to inlicense acquire or invest in complementary businesses technologies products or assets vixs systems tsx vxs is a pioneer and market leader in designing revolutionary media processing semiconductor solutions for video over ip streaming solutions with more than  patents issued and pending worldwide numerous industry awards for innovation and over  million media processors shipped to date vixs is driving the transition to ultra hd k across the entire content value chain by providing professional and consumer grade chipsets that support the new high efficiency video coding hevc standard up to main  profile reducing bandwidth consumption by  while providing the depth of color and image clarity needed to take advantage of higherresolution content vixs’ xcodepro  family is ideal for ultra hd k infrastructure equipment and the xcode  family of systemonchip soc products achieve unprecedented levels of integration that enable manufacturers to create costeffective consumer entertainment devices vixs is headquartered in toronto canada with offices in europe asia and north america vixs™ the vixs® logo xcode® xcodepro™ and xtensiv™ are trademarks andor registered trademarks of vixs other trademarks are the property of their respective owners vixs systems tsx vxs a pioneer and leader in media processing solutions today announced that it has sold its legacy moca multimedia over coaxial alliance business to maxlinear inc nysemxl a leading provider of radio frequency rf and mixedsignal integrated circuits for cable and satellite broadband communications the connected home data center metro longhaul fiber networks and wireless infrastructure this divestiture will allow vixs to focus on its core video business strategies built around delivering bestinclass uhdhdr solutions for the consumer and video delivery market segments vixs plans to use the sale proceeds to improve its balance sheet and for working capital needed to support customers to achieve profitable growth needham  company acted as exclusive financial advisor to vixs systemssynacor nasdaq sync is the trusted technology development multiplatform services and revenue partner for video internet and communications providers device manufacturers and enterprises synacor’s mission is to enable its customers to better engage with their consumers its customers use synacor’s technology platforms and services to scale their businesses and extend their subscriber relationships synacor delivers managed portals advertising solutions email and collaboration platforms endtoend video solutions and cloudbased identity management synacor inc raised  million in its followon offering at  per share needham acted as joint bookrunner on the transaction the company’s underwriters exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by synacor inc for general corporate purposes which may include working capital capital expenditures other corporate expenses and acquisitions of complementary products technologies or businesseseverbridge inc nasdaq evbg is a global software company that provides enterprise software applications that automate and accelerate an organization’s operational response to critical events in order to keep people safe and businesses running during public safety threats such as active shooter situations terrorist attacks or severe weather conditions as well as critical business events such as it outages or cyberattacks over  global customers rely on the company’s saasbased platform to quickly and reliably aggregate and assess threat data locate people at risk and responders able to assist automate the execution of predefined communications processes and track progress on executing response plans the company’s platform sent over  billion messages in  and offers the ability to reach more than  countries and territories with secure delivery to over  different communication devices the company’s critical communications and enterprise safety applications which include mass notification incident management it alerting safety connection™ community engagement™ secure messaging visual command center and crisis commander are easytouse and deploy secure highly scalable and reliable everbridge serves  of the  largest us cities  of the  largest usbased investment banks all four of the largest global accounting firms  of the  busiest north american airports and  of the  largest global automakers everbridge is based in boston and los angeles with additional offices in san francisco lansing beijing london and stockholmeverbridge inc raised  million in its upsized followon offering consisting of both primary and secondary shares at  per share needham acted as comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by everbridge inc for for general corporate purposes including working capital and capital expenditures everbridge will not receive any proceeds from the sale of shares sold by the selling stockholders gigpeak inc nyse mktgig is a leading innovator of semiconductor ics and software solutions for highspeed connectivity and highquality video compression over the network and the cloud the focus of the company is to develop and deliver products that enable lower power consumption and faster data connectivity more efficient use of network infrastructure broader connectivity to the cloud and reduce the total cost of ownership of existing network pipes from the core to the end user gigpeak addresses both the speed of data transmission and the amount of bandwidth the data consumes within the network and provides solutions that increase the efficiency of the internet of things leveraging its strength in highspeed connectivity and highquality video compression the extended product portfolio provides more flexibility to support changing market requirements from ics and mmics through full software programmability and costefficient custom asicsgigipeak inc a manufacturer of semiconductor ics and software solutions for highspeed connectivity and highquality video compression over the network and the cloud completed its previously announced sale to integrated device technology nasdaq idti a global leader in mixed signal semiconductor solutions for the advanced communications computing and consumer industries for  per share in cash or approximately  million the acquisition of gigpeak provides idt with a highly regarded optical interconnect product and technology business that is complementary to idts leadership position in realtime interconnect products needham  company acted as a financial advisor to gigpeak incessen bioscience inc develops and manufactures instruments software reagents and consumables which enable researchers to remotely image and quantitate a wide variety of cellular processes over time the incucyte® system is a realtime quantitative livecell analysis platform that enables visualization and quantification of cell behavior over time by automatically gathering and analyzing images around the clock within a standard laboratory incubator the system allows researchers to make timelapsed fully kinetic measurements from living cells over days and weeks thus providing insight into active biological processes in real time the company was founded in ann arbor michigan in essen bioscience inc a pioneer and leader in the field of cellbased assays and instrumentation used for life sciences research completed its previously announced sale to sartorius group ag fwb srt a leading partner to the biopharmaceutical industry and laboratories for  million through this acquisition sartorius will significantly expand its portfolio for bioanalytics a field the company has recently entered via the intellicyt acquisition in  needham  company acted as a financial advisor to essen bioscience inccara therapeutics nasdaq cara is a clinicalstage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors cara is developing a novel and proprietary class of product candidates led by cr that target the bodys peripheral nervous system and have demonstrated in phase  trials preliminary efficacy in patients with moderatetosevere pain and pruritus without inducing many of the undesirable side effects typically associated with currently available pain therapeuticscara therapeutics inc raised  million in its followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by cara therapeutics inc to fund the companys clinical and research development activities including the completion of the phase  program for iv cr in uremic pruritus two phase  trials of iv cr in acute pain and a phase b trial of oral cr in osteoarthritis pain as well as for working capital and general corporate purposesanalogix semiconductor inc designs and manufactures semiconductors for the digital multimedia market from portable devices such as smartphones to highend graphics cards and large highdefinition displays analogix is the market leader in providing endtoend interface connectivity semiconductor solutions for displayport including highspeed signal conditioners and the slimport family of products and an industry leader in mobile display controllers such as lowpower highspeed timing controller solutions the displayport standard is an innovative packetized digital interface for highresolution video and audio that was developed by the video electronics standards association vesa slimport branded products are compliant with displayport mobility displayport mydp and displayport alternate mode over the usb typec connector analogix semiconductor inc a global leader in designing highperformance mixedsignal semiconductors that enable “hd everywhere” the goanywhere anymobiletoanyscreen highdefinition experience completed its previously announced sale to beijing shanhai capital management co ltd shanhai capital a pioneer buyout fund in healthcare and technology managing rmb and usddenominated funds enhanced by the strong financial support of its new investors analogix will continue building and growing the company into a global leader in highperformance semiconductors needham  company acted as a financial advisor to analogix semiconductor inccryoport inc nasdaq cyrx is the life sciences industrys most trusted global provider of cold chain logistics solutions for temperaturesensitive life sciences commodities serving the biopharmaceutical market with leadingedge logistics solutions for biologic materials such as regenerative medicine including immunotherapies stem cells and cart cells cryoports solutions are used by pointsofcare cros central laboratories pharmaceutical companies manufacturers university researchers et al as well as the reproductive medicine market primarily in ivf and surrogacy and the animal health market primarily in the areas of vaccines and reproduction cryoports proprietary cryoport express® shippers cryoportal™ logistics management platform leadingedge smartpak ii™ condition monitoring system and geosensing technology paired with unparalleled cold chain logistics expertise and  client support make cryoport the endtoend cold chain logistics partner that the industry trustscryoport inc raised  million in its followon offering at  per share needham acted as jointbookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by cryoport inc for business growth including as working capital and for other general corporate purposesevrythng is the internet of things smart products platform connecting consumer products to the web and managing realtime data to drive applications and analytics throughout the product lifecycleevrythng completed the pricing of its  million series b funding round led by san franciscobased sway ventures and also including torontobased generation ventures and londonbased bloc ventures needham acted as sole placement agent for this transaction the new investors join a strong base of existing backers including cisco investments samsung bhlp atomico dawn capital and advance vixeid partners the funding will support evrythng’s growth through partnerships the expansion of its team and continued development of its enterprisefocused iot platform for managing intelligent software identities in the cloud and digital lifecycle applications for product manufacturersaxt inc nasdaq axti designs develops manufactures and distributes highperformance compound and single element semiconductor substrates comprising indium phosphide inp gallium arsenide gaas and germanium ge through its manufacturing facilities in beijing china in addition axt maintains its sales administration and customer service functions at its headquarters in fremont california the company’s substrate products can be used primarily in fiber optic communications d sensing solar cell lighting display applications and wireless communications its vertical gradient freeze vgf technique for manufacturing semiconductor substrates provides significant benefits over other methods and enabled axt to become a leading manufacturer of such substrates axt has manufacturing facilities in china and as part of its supply chain strategy has partial ownership in ten companies in china producing raw materialsaxt technology inc raised  million in its followon offering at  per share needham acted as the sole bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by axt inc for general corporate purposes which may include the relocation of its gallium arsenide product line working capital capital expenditures and other corporate expensesdermira inc nasdaq derm is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated new therapies to the millions of patients living with chronic skin conditions dermira is committed to understanding the needs of both patients and physicians and using its insight to identify and develop leadingedge medical dermatology programs dermira’s product pipeline includes three phase  product candidates that could have a profound impact on the lives of patients glycopyrronium tosylate in development for the treatment of primary axillary hyperhidrosis excessive underarm sweating cimzia® certolizumab pegol in development in collaboration with ucb pharma sa for the treatment of moderatetosevere chronic plaque psoriasis and olumacostat glasaretil in development for the treatment of acne vulgaris dermira is headquartered in menlo park california dermira inc raised  million in its upsized followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by dermira inc for general corporate purposes which may include working capital capital expenditures other corporate expenses and acquisitions of complementary products technologies or businesses in addition it will enable ucb to submit an sbla to the fda for potential approval of cimzia complete registrationenabling activities and submit an nda to the fda for potential approval related to glycopyrronium tosylate enable the company to complete and generate topline results from their ongoing phase  pivotal clinical trials for olumacostat glasaretil commercialize their cimzia and glycopyrronium tosylate product candidates assuming that the company receives the necessary regulatory approvals complete registrationenabling activities and submit an nda to the fda for potential approval related to olumacostat glasaretil assuming the data from their phase  clinical trials are positive and commence potential lifecycle management activities related to their glycopyrronium tosylate and olumacostat glasaretil product candidates the trade desk inc nasdaqttd is a technology company that empowers buyers of advertising through its selfservice cloudbased platform ad buyers can create manage and optimize more expressive datadriven digital advertising campaigns across ad formats including display video audio native and social on a multitude of devices such as computers mobile devices and connected tv integrations with major data inventory and publisher partners ensure maximum reach and decisioning capabilities and enterprise apis enable custom development on top of the platform headquartered in ventura ca the trade desk has offices across the united states europe and asiathe trade desk inc raised  million in its upsized followon offering at  per share of class a common stock by certain selling stockholders  needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of class a common stock at the followon offering price to cover overallotments the trade desk will not receive any proceeds from the offeringathersys inc nasdaqathx is an international biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life the company is developing its multistem® cell therapy product a patented adultderived offtheshelf stem cell product initially for disease indications in the neurological cardiovascular and inflammatory and immune disease areas and has several ongoing clinical trials evaluating this potential regenerative medicine product athersys has forged strategic partnerships and collaborations with leading pharmaceutical and biotechnology companies as well as worldrenowned research institutions to further develop its platform and productsathersys inc raised  million in its followon offering at  per share needham acted as lead manager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by athersys inc for working capital and general corporate purposes including funding towards its phase  multistem® administration for stroke treatment and enhanced recovery study masters clinical study and its other ongoing clinical programsapplied micro circuits corporation nasdaq amcc is a global leader in computing andconnectivity solutions for nextgeneration cloud infrastructure and data centers appliedmicro delivers silicon solutions that dramatically lower total cost of ownership corporate headquarters are located in sunnyvale california appliedmicro became a wholly owned subsidiary of macom on applied micro circuits corporation nasdaq amcc a global leader in computing and connectivity solutions completed its previously announced sale to macom technology solutions holdings inc nasdaq mtsi a leading supplier of highperformance rf microwave millimeterwave and lightwave semiconductor products for  million in the form of an exchange offer needham  company acted as exclusive financial advisor to applied micro circuitskornit digital nasdaq krnt develops manufactures and markets industrial digital printing technologies for the garment apparel and textile industries kornit delivers complete solutions including digital printing systems inks consumables software and aftersales support leading the digital directtogarment printing market with its exclusive ecofriendly neopigment printing process kornit caters directly to the changing needs of the textile printing value chain kornit’s technology enables innovative business models based on webtoprint ondemand and mass customization concepts with its immense experience in the directtogarment market kornit also offers a revolutionary approach to the rolltoroll textile printing industry digitally printing with a single ink set onto multiple types of fabric with no additional finishing processes founded in  kornit digital is a global company headquartered in israel with offices in the usa europe and asia pacific and serves customers in more than  countries worldwide kornit digital ltd raised  million in its upsized followon offering public offering of the  ordinary shares  of the shares are being offered by kornit and  of the shares are being offered by shareholders of the company substantially all by the company’s largest shareholder fortissimo capital fund ii israel lp at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by kornit digital for general corporate purposes the company will not receive any of the proceeds from the sale of shares being offered by the selling shareholders exablox is the company reimagining storage exablox solves businesses’ runaway storage costs and information management nightmares by providing a cloudmanaged scaleout objectbased solution that is affordable and easy to use oneblox is an inclusive storage offering that combines an elegant hardware architecture and integrated enterprisegrade software including inline deduplication continuous data protection and disaster recovery exablox’s innovative approach to storage has led to widespread customer traction across verticals including higher education healthcare insurance and the legal as well as fortune  companies as of january   exablox corporation operates as a subsidiary of storagecraft technology corporationexablox corporation the awardwinning company reimagining storage completed its sale to storagecraft the intelligent recovery and backup company storagecraft technology corporation and exablox corporation joined forces to completely focus on helping businesses analyze protect and store their data the new entity is the first company to bring together a new approach that recognizes the disappearing lines between primary and secondary storage as well as between data availability and data protection the terms of the transaction have not been publicly disclosed needham  company acted as exclusive financial advisor to exablox corporation mediafly is an enterprise software company that has worked with some of the most respected global sales organizations the mediafly evolved selling platform™ aligns with every sales training methodology and is a proven technology for helping field sales organizations deliver a dynamic interactive insightful buying experience that ties seamlessly back to crm for the third year in a row mediafly has been recognized by inc magazine as one of the top  fastestgrowing private companies in the us for more information visit wwwmediaflycommediafly a leading enterprise software company designed to help companies transform and evolve how they sell through the delivery of a perfect inperson selling experience announced the closing of a  million growth capital investment from boathouse capital this is the first outside institutional round for the company and will provide mediafly with a financial partner to support industry leading product innovation to meet the growing demand for more effective sales tools from organizations around the world as part of the transaction andy jang vice president at boathouse capital will be joining mediaflys board of directors needham  company acted as exclusive financial advisor to mediafly on this transactionichor holdings ltd nasdaq ichr is a leader in the design engineering and manufacturing of critical fluid delivery subsystems for semiconductor capital equipment our primary offerings include gas and chemical delivery subsystems collectively known as fluid delivery subsystems which are key elements of the process tools used in the manufacturing of semiconductor devices our gas delivery subsystems deliver monitor and control precise quantities of the specialized gases used in semiconductor manufacturing processes such as etch and deposition our chemical delivery subsystems precisely blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes such as electroplating and cleaning we also manufacture certain components for internal use in fluid delivery systems and for direct sales to our customers this vertically integrated portion of our business is primarily focused on metal and plastic parts that are used in gas and chemical systems respectively ichor holdings ltd raised  million in its initial public offering at  per share needham acted as a passive bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by ichor holdings to repay outstanding borrowings under their credit facilities and the remainder for general corporate purposes including funding working capital operating expenses and the selective pursuit of business development opportunities in their focus segment areas impinj nasdaqpi is a leading provider of rain rfid solutions the impinj platform connects billions of everyday items such as apparel medical supplies automobile parts drivers’ licenses food and luggage to applications such as inventory management patient safety asset tracking and item authentication delivering realtime information to businesses about items they create manage transport and sell the impinj platform wirelessly delivers information about these items’ unique identity location and authenticity or item intelligence™ to the digital world which impinj believes is the essence of the internet of thingsimpinj inc raised  million in its followon offering at  per share needham acted as lead manager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the number of shares sold in the offering included  shares sold by impinj and  shares sold by certain selling stockholders the net proceeds from the sale of the shares from the offering will be used by impinj inc for general corporate purposes which may include working capital capital expenditures other corporate expenses and acquisitions of complementary products technologies or businesses impinj did not receive any proceeds from the sale of the shares by the selling stockholdersttm technologies inc nasdaq ttmi is a major global printed circuit board manufacturer focusing on quickturn and technologically advanced pcbs backplane assemblies and electromechanical solutions ttm stands for timetomarket representing how ttms timecritical onestop manufacturing services enable customers to shorten the time required to develop new products and bring them to marketttm technologies inc raised  million in its followon offering of  shares of its common stock by its largest stockholder su sih bvi ltd the “selling stockholder” at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments from the selling stockholder the selling stockholder will receive all of the proceeds from the offering msp corporation is an instrumentation and equipment company creating products for scientific research and industrial applications they are known worldwide for their expertise in micro and nanoparticles and their creative use in research and manufacturing msp is the world leader in cascade impactor technology with products serving the pharmaceutical and aerosol research markets as well nanoparticle generation and measurement technology serving the semiconductor device fabrication market the company offers products through its distribution network worldwide msp corporation was incorporated in  and is based in shoreview minnesota as of november   msp corporation operates as a subsidiary of tsi incorporatedmsp group an instrumentation and equipment company with an expertise in micro and nanoparticles and their creative use in research and manufacturing completed its sale to tsi incorporated an industry leader in the design and production of precision instruments for measurements relating to aerosol science air flow health and safety indoor air quality fluid dynamics and biohazard detection the terms of the transaction have not been publicly disclosed needham  company acted as exclusive financial advisor to msp groupthe chinese consortium of investors was comprised of beijingbased ic design and solutions manufacturer chipone technology co ltd chipone and its financial partner beijing etown international investment  development co ltd etown capital it focuses on technology media and telecommunications clean technology semiconductors and modern information service industry a chinese consortium comprised of beijingbased ic design and solutions manufacturer chipone technology co ltd chipone and its financial partner beijing etown international investment  development co ltd etown capital announced that it has completed the acquisition of the integrated memory logic limited iml subsidiary of exar corporation nyse exar a leading supplier of analog mixedsignal semiconductor components and system solutions serving the industrial highend consumer and infrastructure markets for a net purchase price of  million in cash needham  company acted as exclusive financial advisor to the chinese consortium lavante inc designs and develops a cloudbased supplier information management sim and profit recovery system for fortune  companies the company offers lavante sim a transformational tool to manage and validate supplier profile automatically lavante recovery an ondemand recovery auditing solution and lavante connect a platform for connecting companies and suppliers it serves hospitality retail entertainment manufacturing and medical industries the company was formerly known as auditsolutions inc and changed its name to lavante inc in april  lavante inc was founded in  and is based in san jose california as of october   lavante inc operates as a subsidiary of prgx usa inclavante inc a saasbased procuretopay pp supplier information management sim and recovery audit services firm completed its sale to prgx global inc nasdaq prgx a global leader in recovery audit and spend analytics services the terms of the transaction have not been publicly disclosed needham  company acted as exclusive financial advisor to lavante inctheravance biopharma inc nasdaq tbph is a diversified biopharmaceutical company with the core purpose of creating medicines that help improve the lives of patients suffering from serious illness our pipeline of internally discovered product candidates includes potential bestinclass medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting vibativ® telavancin our first commercial product is a oncedaily dualmechanism antibiotic approved in the us europe and certain other countries for certain difficulttotreat infections revefenacin td is a longacting muscarinic antagonist lama being developed as a potential oncedaily nebulized treatment for chronic obstructive pulmonary disease copd our neprilysin nep inhibitor program is designed to develop selective nep inhibitors for the treatment of a range of major cardiovascular and renal diseases including acute and chronic heart failure hypertension and chronic kidney diseases such as diabetic nephropathy our research efforts are focused in the areas of inflammation and immunology with the goal of designing medicines that provide targeted drug delivery to tissues in the lung and gastrointestinal tract in order to maximize patient benefit and minimize risk the first program to emerge from this research is designed to develop intestinally restricted panjanus kinase jak inhibitors for the treatment of a range of inflammatory intestinal diseases in addition we have an economic interest in future payments that may be made by glaxo group limited or one of its affiliates gsk pursuant to its agreements with innoviva inc relating to certain drug development programs including the closed triple the combination of fluticasone furoate umeclidinium and vilanterol currently in development for the treatment of copd and asthma for more information please visit wwwtheravancecomtheravance biopharma inc raised  million in its followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by theravance biopharma inc for general corporate purposes which may include among other things research activities preclinical and clinical development of product candidates manufacture of preclinical clinical and commercial drug supplies selling and marketing expenses capital expenditures working capital general and administrative expenses and acquisitions of technology or drug candidatestheravance biopharma inc nasdaq tbph is a diversified biopharmaceutical company with the core purpose of creating medicines that help improve the lives of patients suffering from serious illness our pipeline of internally discovered product candidates includes potential bestinclass medicines to address the unmet needs of patients being treated for serious conditions primarily in the acute care setting vibativ® telavancin our first commercial product is a oncedaily dualmechanism antibiotic approved in the us europe and certain other countries for certain difficulttotreat infections revefenacin td is a longacting muscarinic antagonist lama being developed as a potential oncedaily nebulized treatment for chronic obstructive pulmonary disease copd our neprilysin nep inhibitor program is designed to develop selective nep inhibitors for the treatment of a range of major cardiovascular and renal diseases including acute and chronic heart failure hypertension and chronic kidney diseases such as diabetic nephropathy our research efforts are focused in the areas of inflammation and immunology with the goal of designing medicines that provide targeted drug delivery to tissues in the lung and gastrointestinal tract in order to maximize patient benefit and minimize risk the first program to emerge from this research is designed to develop intestinally restricted panjanus kinase jak inhibitors for the treatment of a range of inflammatory intestinal diseases in addition we have an economic interest in future payments that may be made by glaxo group limited or one of its affiliates gsk pursuant to its agreements with innoviva inc relating to certain drug development programs including the closed triple the combination of fluticasone furoate umeclidinium and vilanterol currently in development for the treatment of copd and asthma for more information please visit wwwtheravancecomtheravance biopharma inc issued  million principal amount of convertible senior notes due  the notes will be general unsecured obligations of the company and will pay interest semiannually on may  and november  of each year at a rate of  per year the initial conversion rate of the notes is  ordinary shares per  principal amount of the notes which is equivalent to an initial conversion price of approximately  per share and will be subject to adjustment upon the occurrence of certain events the initial conversion price represents a conversion premium of approximately  over the sale price of ordinary shares sold in the shares offering the notes will mature on november   unless earlier repurchased or converted the notes will be convertible into ordinary shares of the company at the thenapplicable conversion rate until the close of business on the second business day immediately preceding the stated maturity date the notes will not be redeemable at the companys option prior to maturity except in connection with certain changes in tax laws holders of the notes will have the right to require the company to repurchase all or any portion of their notes at  of their principal amount plus any accrued and unpaid interest upon the occurrence of certain fundamental change events the underwriters fully exercised their option to purchase an additional  million in aggregate principal amount of debentures to cover overallotments needham  company acted as a comanager for this transaction the company intends to use the net proceeds of the offerings for general corporate purposes which may include among other things research activities preclinical and clinical development of product candidates manufacture of preclinical clinical and commercial drug supplies selling and marketing expenses capital expenditures working capital general and administrative expenses and acquisitions of technology or drug candidatesquantenna communications inc nasdaq qnta is a provider of highperformance wifi solutions quantenna’s solutions combine semiconductor architecture with systemlevel software and cloud analytics with the goal of delivering the highest speed broadest coverage highest capacity and most reliable performance quantenna’s solutions primarily serve the nonmobile device market quantenna communications inc raised  million in its initial public offering at  per share needham acted as a comanager on the transaction the company’s underwriters exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by quantenna communications for general corporate purposes including working capital operating expenses and capital expenditures the company may also use a portion of the net proceeds to acquire complementary businesses products services or technologies collegium pharmaceutical inc nasdaqcoll is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patentprotected deterx technology platform for the treatment of chronic pain the deterx oral drug delivery technology is designed to provide extendedrelease delivery unique abusedeterrent properties and flexible dose administration optionscollegium pharmaceutical inc raised  million in its followon offering at  per share needham acted as a colead manager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by collegium pharmaceutical inc for the continued commercialization of xtampza funding research and development efforts of its other product candidates and working capital and general corporate purposes which may include the acquisition or licensing of product candidates technologies compounds other assets or complementary businesseseverspin technologies nasdaq mram is the leading provider of mram solutions everspin’s mram solutions offer the persistence of nonvolatile memory with the speed and endurance of random access memory ram and enable the protection of mission critical data particularly in the event of power interruption or failure everspin’s mram solutions allow its customers in the industrial automotive and transportation and enterprise storage markets to design high performance power efficient and reliable systems without the need for bulky batteries or capacitors everspin is the only provider of commercially available mram solutions and over the past eight years has shipped over  million mram units for more information visit wwweverspincomeverspin technologies raised  million in its initial public offering at  per share needham acted as a jointbookrunner on the transaction the net proceeds from the sale of the shares will be used by everspin technologies for are to obtain additional capital to create a public market for our common stock and to facilitate future access to the public equity markets the company expects to use the net proceeds received from this offering for working capital and other general corporate purposes including an estimated payment of  million due to globalfoundries in december  research and development activities sales and marketing activities and capital expenditures to enhance existing and develop new products expand our manufacturing capabilities and to fund growth acacia communications nasdaq acia develops manufactures and sells highspeed coherent optical interconnect products that are designed to transform communications networks through improvements in performance capacity and cost by converting optical interconnect technology to a siliconbased technology a process acacia refers to as the “siliconization of optical interconnect” acacia is able to offer products that meet the needs of cloud and service provider customers in a simple open highperformance form factor that can be easily integrated in a costeffective manner with existing network equipmentacacia communications inc raised  million in its followon offering at  per share the offering consists of  shares from acacia communications and  shares from certain existing stockholders needham acted as a comanager on the transaction the net proceeds from the sale of the shares from the offering will be used by acacia communications inc for working capital and general corporate purposes acacia communications will not receive any of the proceeds from any sale of shares by the selling stockholdersnutanix inc nasdaq ntnx makes infrastructure invisible elevating it to focus on the applications and services that power their business the nutanix enterprise cloud platform leverages webscale engineering and consumergrade design to natively converge compute virtualization and storage into a resilient softwaredefined solution with rich machine intelligence the result is predictable performance cloudlike infrastructure consumption robust security and seamless application mobility for a broad range of enterprise applications nutanix inc raised  million in its upsized initial public offering of class a common stock at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by nutanix inc for general corporate purposes including working capital sales and marketing activities research and development and general and administrative matterssarepta therapeutics nasdaq srpt is a biopharmaceutical company focused on the discovery and development of unique rnatargeted therapeutics for the treatment of rare neuromuscular diseases the company is primarily focused on rapidly advancing the development of its potentially diseasemodifying dmd drug candidates including exondys  designed to skip exon  and approved under the accelerated approval pathway sarepta therapeutics inc raised  million in its followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by sarepta therapeutics inc principally for the continuation and initiation of further clinical trials commercialization manufacturing business development activities including the potential licensing or acquisition of complementary products and technologies and other general corporate purposesoclaro inc nasdaq oclr is a leader in optical components modules and subsystems for the core optical enterprise and data center markets leveraging more than three decades of laser technology innovation photonics integration and subsystem design oclaros solutions are at the heart of the fast optical networks and highspeed interconnects driving the next wave of streaming video cloud computing voice over ip and other bandwidthintensive and highspeed applicationsoclaro inc raised  million in its upsized followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by oclaro inc for general corporate purposes including working capital capital expenditures other corporate expenses and acquisitions of complementary products technologies or businesses the trade desk inc nasdaq ttd is a technology company that empowers buyers of advertising through its selfservice cloudbased platform ad buyers can create manage and optimize more expressive datadriven digital advertising campaigns across ad formats including display video audio native and social on a multitude of devices such as computers mobile devices and connected tv integrations with major data inventory and publisher partners ensure maximum reach and decisioning capabilities and enterprise apis enable custom development on top of the platform headquartered in ventura ca the trade desk has offices across the united states europe and asia the trade desk inc raised  million in its initial public offering of its class a common stock at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the trade desk will not receive any proceeds from the sale of shares by the selling stockholdersaquinox pharmaceuticals inc aquinox nasdaqaqxp is a clinicalstage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immunooncology aquinoxs lead drug candidate aqx is a small molecule activator of ship suitable for oral once daily dosing with a successful phase  clinical trial completed in  aquinox initiated a phase  trial in  leadership  with aqx for treatment of icbps aquinox has a broad intellectual property portfolio and pipeline of preclinical drug candidates that activate shipaquinox pharmaceuticals inc raised  million in its followon offering at  per share needham acted as a lead manager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by aquinox pharmaceuticals inc to fund additional clinical development of aqx and to fund precommercial and market assessment activities research and development costs to advance its pipeline of preclinical product candidates and for working capital and other general corporate purposesdfmsim provides advanced enabling software solutions to the global semiconductor industry the companys technology simulates key ic design and processing steps to quickly find and avoid systemic defects that threaten yields and increase manufacturing costs dfmsims solutions are versatile modular easy to use and can be rapidly configured for various manufacturing processes and tools headquartered in silicon valley the company maintains rd sales and support offices in multiple global locationsdfmsim inc a leader in chip simulation technology completed its sale to applied materials nasdaq amat the global leader in providing innovative equipment services and software to enable the manufacture of advanced semiconductor flat panel display and solar photovoltaic products the terms of the transaction have not been publicly disclosed needham  company acted as the exclusive financial advisor to dfmsim incinphi corporation nyse iphi is a leader in highspeed data movement we move big data  fast throughout the globe between data centers and inside data centers inphis expertise in signal integrity results in reliable data delivery at high speeds over a variety of distances as data volumes ramp exponentially due to video streaming social media cloudbased services and wireless infrastructure the need for speed has never been greater thats where we come in customers rely on inphis solutions to develop and build out the service provider and cloud infrastructures and data centers of tomorrowinphi corporation issued  million principal amount of convertible senior notes due  in an upsized transaction to qualified institutional buyers pursuant to an exemption from the registration requirements of the securities act of  as amended the “securities act” inphi will settle conversions of the notes by paying or delivering as the case may be cash shares of its common stock or a combination of cash and shares of its common stock at its election in addition holders may require inphi to repurchase their notes upon the occurrence of a fundamental change as defined in the indenture governing the notes at a purchase price equal to the principal amount thereof plus accrued and unpaid interest to but excluding the repurchase date the underwriters fully exercised their option to purchase an additional  million in aggregate principal amount of notes to cover overallotments needham  company acted as a comanager for this transaction inphi intends to use a portion of the net proceeds from the offering of the notes to pay the cost of certain capped call transactions inphi intends to use the remainder of the net proceeds from the offering of the notes for general corporate purposes including financing potential acquisitions and other strategic transactionsemc corporation nyseemc is a global leader in enabling businesses and service providers to transform their operations and deliver it as a service fundamental to this transformation is cloud computing through innovative products and services emc accelerates the journey to cloud computing helping it departments to store manage protect and analyze their most valuable asset – information – in a more agile trusted and costefficient way emc corporation nyse emc a global leader in enabling businesses and service providers to transform their operations and deliver it as a service completed its historic previously announced sale to dell technologies creating a unique family of businesses that provides the essential infrastructure for organizations to build their digital future transform it and protect their most important asset information this combination creates a  billion market leader with an expansive technology portfolio that solves complex problems for customers in the industry’s fastgrowing areas of hybrid cloud softwaredefined data center converged infrastructure platformasaservice data analytics mobility and cybersecurity under the terms of the transaction emc shareholders received  per share in cash in addition to tracking stock linked to a portion of emc’s economic interest in the vmware business based on the estimated number of emc shares outstanding at close emc shareholders received  shares of new tracking stock nyse dvmt for each emc share it is the largest technology transaction on record and dell technologies now becomes the world’s largest privatelycontrolled technology company needham  company acted as a financial advisor to emc on this transaction galvanize is a dynamic tech learning community that offers education workspace and networking for students startups and large companies galvanize teaches web development data science and data engineering to students offers support and workspace to over  member companies and provides over  networking events across nine urban campuses throughout the nation galvanize campuses bring together entrepreneurs students investors mentors and great people and companies to develop the skills mindset and networks necessary to thrive in a technology driven world galvanize inc a market leader delivering technology education programs and community workspaces announced a  million series b investment led by abs capital partners a leading latestage growth company investor colorado impact fund haystack partners greg maffei aspen grove capital and existing investor university ventures also participated needham acted as financial advisor and sole agent to galvanize on this transaction the funding will be used to provide more students access to galvanize’s modern web development and data science programs and directly address employer’s needs to reskill existing employees as a result of the financing paul mariani a general partner with abs capital will join the galvanize board of directorsacadia pharmaceuticals inc nasdaq acad is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disordersacadia pharmaceuticals inc raised  million in its followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by acadia pharmaceuticals inc for to fund commercialization efforts for nuplazid ongoing and new clinical trials and development efforts for pimavanserin and for general corporate purposes which may include research development and commercialization expenses capital expenditures working capital and sales general and administrative expenses the company may also use a portion of the net proceeds to acquire or invest in complementary businesses products and technologiesdigimarc corporation nasdaq dmrc based in beaverton oregon is the inventor of the digimarc discover® platform featuring the imperceptible digimarc barcode for automatically identifying and interacting with virtually any media digimarc owns an extensive intellectual property portfolio with patents in digital watermarking content identification and management media object discovery and intuitive computing more generally digimarc inc raised  million in its upsized followon offering at  per share needham acted as the joint bookrunner on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by digimarc inc for for general working capital purposes as well as to accelerate the company’s growth initiatives these growth initiatives include increasing sales marketing and operations resources for global expansion supporting a growing supplier network and feasibility and pilot projects with prospective customers continuing development of tools and processes to support efficient effective and timely implementation of its technology and further research and intellectual property development unboundid provides the industry’s leading software platform for customer identity and access management enterprise customers select the unboundid platform to modernize traditional identity and access management systems and enable new customerfacing digital business initiatives that provide realtime personalization and delivery of a consistent customer experience across channels and devices some of the world’s largest and most demanding companies in financial services retail hospitality telecommunications and healthcare rely on unboundid to manage and protect their identity and preference data across application portfolios and systems of engagement unboundid customers consistently report a total cost of ownership savings between  to  percent relative to legacy directory servers and the company enjoys a  customer renewal rate unboundid a market leading provider of customer identity and access management software to help enterprises improve customer engagement completed its sale to ping identity the leader in identity defined security terms of the transaction were not disclosed the deal puts ping identity which is owned by vista equity partners firmly in at the intersection of identity and customer engagement and management the combined company provides identity and access management solutions for the world’s leading companies including over half of the fortune  and manages over  billion identities needham  company acted as the exclusive financial advisor to unboundidellie mae inc nyseelli is a leading provider of innovative ondemand software solutions and services for the residential mortgage industry mortgage lenders of all sizes use ellie mae’s encompass® allinone mortgage management solution mavent compliance service and allregs research reference and education resources to improve compliance loan quality and efficiency across the entire mortgage lifecycleellie mae inc raised  million in its followon offering at  per share needham acted as a comanager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the followon offering price to cover overallotments the net proceeds from the sale of the shares from the offering will be used by ellie mae inc for general corporate purposes which may include working capital capital expenditures other corporate expenses and acquisitions of complementary products technologies or businessesargos therapeutics nasdaq args is an immunooncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases using its arcelis® technology platform argos most advanced product candidate ags is being evaluated in the pivotal adapt phase  clinical trial for the treatment of metastatic renal cell carcinoma mrcc in addition ags is being studied in phase  investigatorinitiated clinical trials as neoadjuvant therapy for renal cell carcinoma rcc and for the treatment of nonsmall cell lung cancer nsclc argos is also developing a separate arcelis®based product candidate ags for the treatment of human immunodeficiency virus hiv which is currently being evaluated in an investigatorinitiated phase  clinical trial aimed at hiv eradication in adult patientsargos therapeutics inc raised  million in its followon offering at  per share of common stock and accompanying warrants  needham acted as the lead manager on the transaction the net proceeds from the sale of the shares from the offering will be used by argos therapeutics inc to fund their pivotal phase  adapt trial of ags the ongoing and planned investigatorinitiated phase  clinical trials of ags their share of the expected costs of the leasing buildout and equipping of a commercial manufacturing facility and activities in preparation for the submission of a bla to the fda for ags and for working capital and other general corporate purposes nicox bloomberg coxfp reuters ncoxpa is an international ophthalmic rd company aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the worldnicox sa completed the pricing of an offering a reserved capital increase of ordinary shares of the company to a specific category of investors the gross proceeds of the financing are approximately € million for a total of  million new shares needham acted as lead placement agent for this transaction the net proceeds from the sale of the units will be used by nicox sa for clinical development of pipeline candidates ncx  in blepharitis and ncx  in glaucoma working capital and general corporate purposesimpinj nasdaq pi is a leading provider of rain rfid solutions the impinj platform connects billions of everyday items such as apparel medical supplies automobile parts drivers’ licenses food and luggage to applications such as inventory management patient safety asset tracking and item authentication delivering realtime information to businesses about items they create manage transport and sell the impinj platform wirelessly delivers information about these items’ unique identity location and authenticity or item intelligence™ to the digital world which impinj believes is the essence of the internet of things impinj inc raised  million in its upsized initial public offering at  per share needham acted as a lead manager on the transaction the company’s underwriters fully exercised their option to purchase an additional  shares of common stock at the initial public offering price to cover overallotments the net proceeds from the sale of the shares will be used by impinj inc to repay  million of indebtedness under the mezzanine credit facility and the remainder will be used for working capital and other general corporate purposesformfactor inc nasdaq form helps semiconductor manufacturers test the integrated circuits ics that power consumer mobile devices as well as computing automotive and other applications the company is one of the world’s leading providers of essential wafer test technologies and expertise with an extensive portfolio of highperformance probe cards for dram flash and soc devices customers use formfactor’s products and services to lower overall production costs improve their yields and enable complex nextgeneration ics headquartered in livermore california the company services its customers from a network of facilities in europe asia and north americaformfactor inc nasdaqform announced that it has completed the acquisition of cascade microtech inc nasdaq cscda worldwide leader in precision contact electrical measurement and test of integrated circuits ics optical devices and other small structures for a net purchase price of  million in cash and stock needham  company acted as the exclusive financial advisor and provided a fairness opinion to the board of directors of formfactor inc as part of its services events august   needham  companys sixth annual industrial technologies x conference august   nd annual needham medtech x conference news july   needham  company starts proofpoint pfpt at buy streetinsidercom   july   needham  company starts express scripts esrx at hold streetinsidercom   july   update needham  company starts diplomat pharmacy dplo at buy streetinsidercom     needham  company llc  needham funds  needham capital partners  the needham group inc needham  company llc is a member of finra  sipc all rights reserved terms of use  privacy policy  business continuity plan designed and developed by piehead productions llc the needham funds inc  needham growth fund private company information  bloomberg july    pm et capital markets company overview of the needham funds inc  needham growth fund snapshot people company overview the needham funds inc  needham growth fund is an openended equity mutual fund launched and managed by needham investment management llc the fund invests in the public equity markets of the united states it invests in stocks of companies operating across diversified sectors the fund invests in the growth oriented value stocks of companies operating across all market capitalizations it employs a fundamental analysis focusing on factors like longterm value strong growth potential strong incentivized management team high operating margins overall growth prospects financial conditions competitive positions technology research and development productivity labor costs raw ma the needham funds inc  needham growth fund is an openended equity mutual fund launched and managed by needham investment management llc the fund invests in the public equity markets of the united states it invests in stocks of companies operating across diversified sectors the fund invests in the growth oriented value stocks of companies operating across all market capitalizations it employs a fundamental analysis focusing on factors like longterm value strong growth potential strong incentivized management team high operating margins overall growth prospects financial conditions competitive positions technology research and development productivity labor costs raw materials costs and sources competitive operating margins return on investment and managements to create its portfolio the fund benchmarks the performance of its portfolio against the nasdaq composite index the sp  index the sp  midcap index and the russell  index the needham funds inc  needham growth fund was formed on january   and is domiciled in the united states detailed description  park avenueth floornew york ny united statesfounded in  phone  fax  wwwneedhamfundscomfundsgrowthhtml key executives for the needham funds inc  needham growth fund mr george austin needham chairman and president age  mr james w giangrasso chief financial officer secretary and treasurer age  mr christopher john retzler portfolio manager age  mr john oliver barr portfolio manager age  mr james michael abbruzzese chief compliance officer age  compensation as of fiscal year  similar private companies by industry company name region visory llc united states  road partners llc united states t partners llc united states jumpcom inc united states  ontario inc united states recent private companies transactions typedate target no transactions available in the past  months request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states bertelsmann ag europe the advertising council inc united states rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact the needham funds inc  needham growth fund please visit wwwneedhamfundscomfundsgrowthhtml company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close needham funds inc  relationship science news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink needham funds inc overview executives  employees board of directors paths needham funds inc overview headquarters  park avenue new york ny  website httpwwwneedhamfundscom executives  employees christopher john retzler portfolio manager john oliver barr jr portfolio manager see our list of current and previous employees when you upgrade start my free trial ➤ see more board of directors john william larson counsel at morgan lewis  bockius llp see our list of current and previous board members when you upgrade start my free trial ➤ see more paths to needham funds inc needham funds inc you connections via relationship science needham funds inc sync your contacts to see how you can connect with needham funds inc start my free trial ➤ see more youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ needham funds inc needham funds portfolio manager commentary this site is a collection of past issues of our portfolio managers regular commentary the growth factor the growth factor is a series of regular commentary published by needham funds portfolio managers john barr and chris retzler and cfo jim giangrasso  in their monthly missives john chris and jim lend their viewpoint on thematic investing in growth stocks and discuss market and macroeconomic trends   please visit wwwneedhamfundscom for up to date fund information  if you have questions or comments please contact kathleen mumma at  kmummaneedhamcocom       the growth factor the growth factor vol   active share  low turnover  the growth factor vol   ngc  preview  the growth factor vol   second act investing  the growth factor vol   the wow factor  the growth factor vol   the th americas cup  lessons in management  the growth factor vol   needham  co healthcare conference  grants spring  conference  the growth factor vol   profile of makism d a penny stock  the growth factor vol   preview of needham growth conference  the growth factor vol   in pursuit of tenbaggers  the growth factor vol   are we in a bubble we say no but be careful out there  the growth factor vol   preview of grants investment conference  the growth factor vol   investment criteria and a few of our new stocks  the growth factor vol   the wow factor  the growth factor vol   why dividends matter  the growth factor vol   preview of needham growth conference  the growth factor vol   one up on wall street  the growth factor vol   iphone  apples implications across our portfolios  the growth factor vol   is the market rigged against the retail investor  the growth factor vol   on the road with chris  john   join our mailing list the information presented in this commentary is not intended as personalized investment advice and does not constitute a recommendation to buy or sell a particular security or other investments   this message is not an offer of the needham growth fund the needham aggressive growth fund or the needham small cap growth fund shares are sold only through the currently effective prospectus please read the prospectus and consider the investment objectives risks and charges and expenses of the fund carefully before you invest the prospectus contains this and other information about the fund   investment returns and principal value will fluctuate and when redeemed shares may be worth more or less than their original cost shares held  days or less are subject to a shortterm redemption fee of  past performance does not guarantee future results and current performance may be higher or lower than these results  current monthend performance and a copy of the prospectus is available at wwwneedhamfundscom or by contacting the funds transfer agent us bancorp fund services llc at    funds holding smaller capitalized companies are subject to greater price fluctuation than those of larger companies also the funds use of short sales options futures strategies and leverage may result in significant capital loss total return figures include reinvestment of all dividends and capital gains needham  company llc member finra sipc is the distributor of the needham funds inc needham  company  contact the needham group skip navigation home search client access about us news contact us about us overviewtransaction historymanagementcareers firm culturecareer opportunitiessubmit resume september th scholarship fund institutional sales  trading overviewsalestradingmarket maker list and disclosuresteam leadershipsalestrading conferences equity research overviewcoverage universe with disclosuresteam leadershipclean technologiescommunications  enterprise infrastructurehealthcareindustrial  diversified growthinternet entertainment  consumersemiconductors  semiconductor equipmentsoftware  services equity research client login conference  event calendar investment banking overviewcorporate finance industry focusproduct focus public equity offeringsmergers  acquisitionsprivate capital marketsspecial situations  restructurings team leadershipchina investment bankingclean technologycommunicationsenterprise infrastructurefinancial serviceshealthcareindustrial  diversified growthinternet digital media  consumerisraeli investment bankingsemiconductors  semi equipmentsoftware  servicesmergers  acquisitionsprivate capital marketscapital markets corporate  venture services corporate servicesexecutive servicesventure servicesteamformsclient access private capitaltransaction history asset managementnews needham press releasesother needham newsfor press  media contact new yorkbostonchicagomenlo parksan francisco new york new york needham  company llc  park avenue new york ny  telephone   fax   click here for map  directions boston massachusetts needham  company llc one federal street boston ma  telephone   fax   click here for map  directions chicago illinois needham  company llc  north lasalle suite  chicago il  telephone   fax   click here for map  directions menlo park california needham  company llc  sand hill road building  menlo park ca  telephone   fax   click here for map  directions san francisco california needham  company llc  mission street san francisco ca  telephone   fax   click here for map  directions needham  company llc  needham funds  needham capital partners  the needham group inc needham  company llc is a member of finra  sipc all rights reserved terms of use  privacy policy  business continuity plan designed and developed by piehead productions llc   forbidden access is denied server error   forbidden access is denied you do not have permission to view this directory or page using the credentials that you supplied microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft needham funds  money az  web results aol search skip over navigation search the web web images images best mutual fund  best mutual fund find results ad · referencecom​best mutual fund best mutual fund find results see referencecom related content browse education browse finance browse health browse vehicles top  mutual funds  find top  mutual funds  searchallcom ad · wwwsearchallcom​mutualfunds search for top  mutual funds with s of results at searchallcom best mutual funds top  mutual funds top  mutual funds compare mutual funds best performing mutual funds no load mutual funds mutual funds  find mutual funds in needhamma ad · needhammalocalguidescom find mutual funds in needhamma phone numbers addresses  maps searches related toneedham funds needham mutual funds needham and co needham aggressive growth fund needham small cap growth needham capital partners needham growth conference mutual funds needham ma needham investment management llc web results needhamfunds wwwneedhamfundscom the needham funds have made the following distributions for  needham growth fund neegx  per share long term capital gain needham aggressive growth fund  growth fund manager commentary hedge funds literature center needham  company  wikipedia httpsenwikipediaorgwikineedhamgrowthfund needham  company is an independent investment bank and asset management firm specializing in advisory services and financings for growth companies needham  company  official site wwwneedhamcocom needham  company llc a subsidiary of the needham group inc is a nationally recognized investment banking and asset management firm focused solely on growth  needham capital partners  about us  overview wwwneedhamcapitalcomdefaultaboutusaspx needham capital partners ncp manages funds that invest primarily in the equities of private growth companies focusing entirely on longterm capital appreciation  needham growth fund neegx  us news money moneyusnewscommidcapgrowthneedhamgrowthfundneegx see needham growth fund neegx mutual fund ratings from all the top fund analysts in one place see needham growth fund performance holdings fees risk  needham  company  about us  overview wwwneedhamcocomdefaultaboutusoverviewaspx needham  company llc is a nationally recognized investment banking and asset management firm focused solely on growth companies and their investors the needham funds inc  needham growth fund private  httpswwwbloombergcomresearchstocksprivatesnapshotasp the needham funds inc  needham growth fund company research  investing information find executives and the latest company news needham education foundation funding school grants in  wwwnefneedhamorg needham education foundation raises funds for the enrichment of children in prek through high school to date the nef has given over m for  grants needham group wwwneedhamgrpcom needham funds is affiliated with needham asset management llc nam which currently manages close to  million in public and private equity investments best mutual fund  best mutual fund find results ad · referencecom​best mutual fund best mutual fund find results see referencecom related content browse education browse finance browse health browse vehicles top  mutual funds  find top  mutual funds  searchallcom ad · wwwsearchallcom​mutualfunds search for top  mutual funds with s of results at searchallcom best mutual funds top  mutual funds top  mutual funds compare mutual funds best performing mutual funds no load mutual funds mutual funds  find mutual funds in needhamma ad · needhammalocalguidescom find mutual funds in needhamma phone numbers addresses  maps searches related toneedham funds needham mutual funds needham and co needham aggressive growth fund needham small cap growth needham capital partners needham growth conference mutual funds needham ma needham investment management llc next answers needham  company advisory services institutional sales and trading and equity research asset management needham investment management another wholly owned subsidiary more needham b broughton high school needham b broughton high school commonly known as broughton high school is one of the flagship schools of the wake county public school system it more frederick d sulcer much–needed funds he attended the university of chicago on a scholarship and edited the student newspaper the chicago maroon and graduated in  he more search the web  aol inc all rights reservedprivacy   terms of use   preferences   contact us   powered by bing™ wowcom  part of the aol search network